Podcasts about Monitor

Today, we’re bringing you the best from newsrooms around the PNW… First, computer science researchers at the University of Washington are testing if a phone app can accurately monitor a fetus' heart rate during pregnancy. Next, Washington State University’s Nuclear Science Center is ramping up research and training to meet the increasing need for energy. And finally, Oregon came within one day of announcing it was feral-swine free – and then another wild pig appeared. We can only make Seattle Now because listeners support us. Tap here to make a gift and keep Seattle Now in your feed. Got questions about local news or story ideas to share? We want to hear from you! Email us at seattlenow@kuow.org, leave us a voicemail at (206) 616-6746 or leave us feedback online.See omnystudio.com/listener for privacy information.

If the United States expected Iran to capitulate by now, it refuses to do so. Instead, it is pursuing a survival strategy of fighting on and selecting targets to raise the war's costs so high that the U.S. and Israel would think twice before attacking again. Also: today's stories, including how the disruption of oil-tanker traffic is becoming increasingly urgent for the global economy; how a bipartisan bill aimed at addressing housing affordability that passed through the U.S. Senate could hit a snag in the House of Representatives; and whether Israeli Prime Minister Benjamin Netanyahu can declare victory without a regime change in Iran, despite it being his goal in the war. Join the Monitor's Linda Feldmann for today's news.

David Locke joined DJ & PK to talk about the future makeup of the Utah Jazz in his weekly visit on the show.

American farmers are seeing fertilizer prices spike as supply is choked off by Iran's threats to shipping in the Strait of Hormuz, in response to attacks by the U.S. and Israel. It's a sign of how the war is affecting the global economy – including spring planting. Also: today's stories, including how African students in Iran are finding themselves increasingly affected as the conflict widens; how higher education institutions are tightening their fundraising practices in the wake of the Epstein files; and how “Sinners” has added to the cultural dialogue around what makes a great movie and who gets to make it. Join the Monitor's Kurt Shillinger for today's news.

Break out the spyglass! It’s time to forecast what is coming in 2026 We’ve got 2025 in the rear view window, and Hollywood has determined to not just relegate horror movies into the fall/Halloween schedule. Springtime apparently is a good time to have a big fear injection. So, we had to get the word out on movies you can anticipate coming to a theater near you! Admittedly, we’re out a little late this year. But, I would suggest we are just in time! Surprisingly, there are a lot of horror movies that are being released in late March. It also happens to be the eve of when many of the big genre film festivals get rolling. Sundance has just completed. SXSW is right on us now. Overlook is around the corner. So is Panic Fest. With these festivals, it sets the table for what you all can expect to come out this year. It becomes a bit of a guessing game for those of us who attend these festivals to predict what films are going to be on the schedule. Horror has proven to be profitable in what used to be a dead period for box office. Already, both Iron Lung ($50 million on a $3 million budget) and Send Help ($92 Million) opened up strong in January, traditionally the dumping ground for cast-off studio films. With the tremendous profitability and critical response to last year’s crop of films, we will see what will become this year’s banner carrier. My guess? Scream 7. There isn’t a studio backed big prestige movie like Sinners or Weapons this year, but I could very easily see a Neve Campbell led Scream 7 into a $300 million earner, much like Final Destinations: Bloodline from last year. If Scream 7 lives up to its potential, it could fly past that number. I don’t think that the effect of last year’s horror boom will be felt until next year’s crop. The studios didn’t have enough time to understand the influence until the season largely wrapped in October, well after prduction had wrapped for most films getting released for 2026. A Good Year for Indie Films? The indie horror films are in abundance this year. SXSW has a huge roster of genre films. Overlook just announced their roster, and so has Panic Fest. Usually there is a lot of overlap, but not so much this year. That suggests a wide variety and a lot of options out there. An that’s not taking into account the large Summer and Fall festivals like Frightfest, Popcorn Frights, and Screamfest. As usual, there will be films that we didn’t see coming because they come with zero fanfare, but end up surprising us with original storytelling or raw savagery. Better yet… both! We always summarize what we did from the previous year, and I think we actually did pretty well in our selections for 2025. You can check out last year’s predictions HERE. Will 2026 be as solid for Scariest Things selections? Listen in, and remember this come the end of the year! Episode 209: Looking Forward to 2026 Note… we announced this one episode off. Looking Forward To 2026: The Candidates Dolly (2026) Ready or Not 2: Here I Come (2026) Evil Dead Burn (2026) Hokum (2026) Hungry (2026) Ice Cream Man (2026) Lestat Season 3 The Mummy (2026) Obsession (2026) Scream 7 (2026) Sender (2026) Undertone (2026) Forbidden Fruits (2026) American Dollhouse (2026) Grind (2026) Drag (2026) Never After Dark (2026) Monitor (2026) And Her Body Was Never Found (2026) The Bride (2026) Buddy (2026) Chili Finger (2026) Cold Storage (2026) Faces of Death (2026) Family Movie (2026) Other Mommy (2026) Saccharine (2026) They Will Kill You (2026) Ugly Cry (2026) Break a Leg (2026) Frogman Returns (2026) Bagworm (2026) Anima (2026)

Nora Szentivanyi is joined by Raphael Brun-Aguerre, Michael Hanson and Allan Monks to discuss global inflation developments heading into the Iran conflict; the first-order impact of higher oil prices on headline CPI inflation; the likelihood and magnitude of second-order effects on core inflation and inflation expectations; and how central banks are likely to react to the shock. This podcast was recorded on March 12, 2026. This communication is provided for information purposes only.  Institutional clients can view the related reports at https://www.jpmm.com/research/content/GPS-5216250-0 https://www.jpmm.com/research/content/GPS-5232201-0 https://www.jpmm.com/research/content/GPS-5222819-0 https://www.jpmm.com/research/content/GPS-5222602-0 https://www.jpmm.com/research/content/GPS-5223806-0 https://www.jpmm.com/research/content/GPS-5229672-0   for more information; please visit www.jpmm.com/research/disclosures for important disclosures. © 2026 JPMorgan Chase & Co. All rights reserved. This material or any portion hereof may not be reprinted, sold or redistributed without the written consent of J.P. Morgan. It is strictly prohibited to use or share without prior written consent from J.P. Morgan any research material received from J.P. Morgan or an authorized third-party (“J.P. Morgan Data”) in any third-party artificial intelligence (“AI”) systems or models when such J.P. Morgan Data is accessible by a third-party.  

Firearm storage is not just about what you buy, it's about what you know. In this episode, Mike and Nicky Zabetian from Kinisium join Mike to break down Kini Safe Alert, a small, discreet motion/tamper notification device that texts (or app-notifies) you when something you care about is moved, opened, or accessed.They talk through the real stories that inspired the product, why “my kids know better” is not a plan, and how Kini can add a passive layer of awareness to safes, drawers, cases, ammo storage, and more. You'll also hear how they built the product through COVID-era supply chain chaos, why they designed it to avoid subscriptions, how the settings work (sensitivity, quiet modes, multi-person alerts), and how this kind of tool can complement suicide prevention and responsible ownership without tracking you or your location.Plus: what it's like breaking into the firearms market with a safety product, what they're bringing to SHOT Show, and the question we ask every guest, how do you tend to your mental health?Send a text Walk the Talk America would like to thank our partners who make these conversations possible and would like to highlight our top two partner tiers below! Platinum Tier:RugerArmscorBleeker Street PublicationsGold Tier:NASGWLipsey'sDavidson's

Seit fast sieben Jahren gehört der Video Assistant Referee zum Alltag der Super League – und sorgt fast jedes Wochenende für Diskussionen. Mal wird mit der Lupe nach einem möglichen Foul gesucht, mal dauert es lange, bis die entscheidenden Bilder vorliegen. Und trotz technischer Unterstützung passieren weiterhin Fehler. Doch wie sieht die Arbeit eigentlich hinter den Kulissen aus? Wie anspruchsvoll ist der Job für den Schiedsrichter, der im VAR-Raum in Volketswil am Monitor sitzt? Wie behält man einen kühlen Kopf, während im Stadion tausende Fans und auf Social Media tausende Meinungen warten? Zu Gast in «Dritte Halbzeit» ist Super-League-Rekord-Schiedsrichter Fedayi San. Er gibt einen Einblick in den VAR-Raum in Volketswil, erklärt die Herausforderungen der Arbeit als Video Assistant Referee und spricht darüber, wo der VAR im Schweizer Fussball noch besser werden kann. Diese und weitere Einblicke gibt es in dieser Bonus-Ausgabe der «Dritten Halbzeit».Die Themen: 00:00 Werbung: Spezialangebot von Blue Sport 00:25 Intro 02:16 Die Karriere von Fedayi San 19:17 Im VAR-Raum in Volketswil 56:17 Die Zukunft des VAR In der Dritten Halbzeit wird über den Schweizer Fussball diskutiert. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

U.S. Defense Secretary Pete Hegseth's tone in his public statements about the war in Iran is drawing criticism that it glorifies violence and is posturing that runs counter to professional soldiering. Also: today's stories, including a look at Japan's return to nuclear energy, 11 years after the Fukushima Daiichi nuclear accident; how as the UK's Labour Party tacks right, the Green Party is scooping up its spurned voters; and how locals in Jordan are inviting stranded foreigners to “break-the-fast” evening Ramadan meals amid the stress of war. Join the Monitor's Ira Porter for today's news.

In this episode, host Janet Michael visits the Capon Valley Bank branch in Stephens City to discuss the value of community banking in today's digital age. Melba Thorne shares insights on personalized banking, financial literacy, and how a century-old institution maintains its commitment to local communities. About Capon Valley Bank History: Serving communities since 1918, starting in Wardensville, West Virginia Locations: Five branches across Hardy County (WV) and Frederick County (VA) New expansion: Sixth branch opening May 2026 on Winchester's north side (across from Texas Roadhouse on Ezra's Lane) Parent company: Highland Bank Shares (sister bank to Grant County Bank) Banking Philosophy "Big bank products with hometown service" Focus on personal relationships over sales quotas Loan decisions made locally (no waiting weeks for out-of-state approval) Treating customers as individuals, not numbers Goal: "The Chick-fil-A of banking" - knowing customers by name Services Offered Personal Banking: Checking and savings accounts Home equity lines of credit Auto loans Rewards checking with "UChoose Rewards" program Roundup savings program (automatically rounds purchases to nearest dollar and saves the difference) Business & Commercial Banking: New construction lending (residential and commercial) Commercial lines of credit Small business startup loans SBA loans Agricultural loans Investment property financing (including Airbnb properties) Land loans Renovation loans Financial Tips Credit Score Protection: Limit credit inquiries when car shopping (no more than 2 pulls from dealerships) Multiple credit pulls can dramatically drop your credit score Get pre-approved from your bank before visiting dealerships Target credit score: 680+ (many banks require 700+) Credit Score Factors: Too many credit cards can hurt your score Maxed out credit cards negatively impact your score even if paid on time One missed payment can drop you below 700 Medical issues, divorce, and life events are considered with context Smart Money Habits: Build emergency savings for "rainy days" Use roundup savings programs to save without thinking about it Monitor your credit score regularly through banking apps Don't spend everything left over after paying bills Community Involvement Cram the Cruiser: Annual toy drive in December for Toys for Tots (collects 300+ toys per branch) Partnership with local police and fire departments School volunteer programs and event support Sponsorship of local fairs and festivals (Newtown Heritage Weekend, etc.) Active chamber of commerce participation Community Leadership Program graduate Technology & Convenience Full online banking platform Mobile banking apps Online account applications available Educational learning center on website with product videos Still encourages in-person visits for personalized service Contact Information Website: caponvalleybank.com Phone: 540-868-1140 Direct line to local branch (no call centers!) Commercial Lending: Fred Brooks, Commercial Loan Officer Resources Mentioned Educational videos and learning center at caponvalleybank.com Credit score monitoring apps SBA loan programs

Andy and Brendan are LIVE outside TPC Sawgrass at The Players Championship and ready to review a full day of scuttlebutt, course scouting, and player assessments. They begin with some notes on a Sawgrass setup looking like an attempt to push the pros around in a major-like fashion, supporting the campaign to make this tournament a “major.” Then they discuss Five Guys to Monitor, and not monitor with their worst tee times of the first two days (along with some of their favorites). The also preview what Brian Rolapp might say in his first big address at his first Players, and how few people on site seem to know precisely what is coming but it is the most-discussed subject so far. Will we get a scarcity schedule? Will we get a mule purge? Are the players re-asserting their control over the new regime and Tour structure? Then they hit on some storylines no one is talking about this week, including the LIV Singapore Champions dinner. Finally, they bring in the boys, PJ Clark and Joseph LaMagna, and offer some further notes from the ground before closing with their official picks to win. Thank you to ⁠Optum⁠ for their support of our Players Championship coverage. Visit ⁠Cobalt⁠ and use code "FRIEDEGGPOD15" for 15% off: ⁠https://cobalt-golf.com/discount/FRIEDEGGPOD?redirect=%2Fcollections%2Fdiscountable-products

Ellie Cohanim, former Deputy Special Envoy to Monitor and Combat Anti-Semitism, calls into the morning show to discuss President Trump's remarks yesterday regarding the war in Iran and if she agrees with the President that the conflict will be short-term. Learn more about your ad choices. Visit megaphone.fm/adchoices

Recurring revenue sounds smart. Memberships, prepaid packages, and gift cards can create a surge in cash flow for med spas — but without proper financial tracking, they can distort your profit margins, inflate revenue perception, and create operational risk.  Listen here to learn how aesthetic practices can misinterpret cash injections as true growth — and what to track instead.  If you're operating 1–2 locations and planning to scale, this conversation about healthy cash flow management for your aesthetics practice is critical.  Are Gift Cards Creating False Revenue Expectations for Your Practice?  Whether you run a med spa or a similar practice, you'll learn why simply chasing upfront cash isn't always the ticket to success—and how these models can create a false sense of profitability, throw off your capacity planning, and even compromise your ability to deliver services in the future. I'm revealing how a CFO tracks different income streams, forecasts cash flow, and helps you build sustainable financial habits, so you don't end up borrowing from your future business.  Prepaid revenue can:  Inflate top-line sales  Hide future labor costs  Distort margins  Create scheduling unpredictability  Mask capacity constraints  "The issue with this, however, is when not done well or not done with this in mind, you're putting yourself at risk for a very distorted view of your sales, of your numbers, and not really making sound business decisions based on good data." - Shannon Weinstein  To cut to the chase, cash in the bank does not equal earned revenue.  Cash Injection vs. Sustainable Growth: Making Better Business Decisions  We're seeing a huge trend in med spas and wellness practices: everyone's jumping on the recurring revenue train with memberships, subscriptions, gift cards, and prepaid packages. It sounds great on the surface—more cash in the bank, better sales numbers, right? But here are a few things you'll learn in this episode that might change your mind:  Why gift card revenue is a future liability, not pure profit  How prepaid packages distort med spa profit margins  Why capacity utilization matters more than cash balance  How to segment revenue categories properly in QuickBooks  Why you should reconsider commission structures on prepaid sales  How memberships affect enterprise value and predictability  Protecting Your Aesthetics Practice from Recurring Revenue Traps and Misleading Data  Collecting money upfront (especially around holidays with gift cards) can feel like winning. Who doesn't love a surge in revenue and a healthy bank balance? The catch is, those numbers don't always paint an honest picture. You might be thinking your marketing is working wonders, but really, your sales are getting propped up by gift card purchases. When it comes time to deliver the actual services, your costs catch up—and you don't have new income to cover them.  If your med spa offers memberships, gift cards, or prepaid packages:  Segment revenue by category (services, retail, memberships, gift cards, prepaid packages)  Track redemption timing based on historical data  Build a 6-week cash flow forecast including expected redemptions  Measure revenue per provider and revenue per square foot  Monitor capacity utilization instead of celebrating temporary cash spikes  Evaluate LTV to CAC separately from prepaid sales  I compare it to the GLP-1 weight loss trend: quick results, but they don't last unless your habits are solid. The same goes for business cash injections. If you don't have the right financial habits, you get a false sense of achievement that fades fast.  Memberships and Prepaid Packages: Boost or Bust for Your Med Spa?  If your monthly numbers look amazing, but you're just selling future services, don't rush to expand or boost sales goals. Before expanding, make sure your growth is real by evaluating the following:  Are you mistaking cash injections for sustainable demand?  Is capacity actually full — or artificially inflated?  Are membership liabilities masking thin operating margins?  Buyers and lenders look for predictable earned revenue — not volatile cash surges.  Essential Metrics for Med Spas: Beyond Cash in the Bank  If you're unsure whether your med spa's cash flow is sustainable — or distorted — start with the Financial Scaling Playbook for Aesthetics. Get it today: www.keepwhatyouearn/playbook  Inside the free series, I walk you through:  Identifying your biggest financial constraint  Cash flow forecasting basics  Evaluating offer profit correctly  Preparing your practice for scale  Follow Shannon & Keep What You Earn:   Shannon Weinstein is the founder of a fractional CFO firm specializing in helping 7-figure aesthetics and wellness practices scale with clarity, cash flow, and confidence. Host of the "Keep What You Earn" podcast, Shannon provides practical financial insights and strategies for business owners looking to build truly valuable and sellable practices. She breaks down what it means to create a business buyers will pay a premium for—going beyond surface level metrics to address the essential financial building blocks. Shannon is committed to helping med spa owners understand, fix, and maximize their business's enterprise value, offering actionable advice and resources, including a popular free video series specifically for aesthetics practice owners.   Fractional CFO Services and Executive Financial Review: https://www.keepwhatyouearn.com/  Connect with Shannon: https://www.linkedin.com/in/shannonweinstein  Watch full episodes: https://www.youtube.com/@KeepWhatYouEarn  Listen on your favorite podcast app: https://pod.link/1580071347  Instagram: https://www.instagram.com/shannonkweinstein/    The information shared is for educational purposes only and is not individualized financial advice. Aesthetics practice owners should consult a qualified professional before implementing financial strategies discussed here. 

Choosing continuity amid war, Iran named Mojtaba Khamenei to succeed his father, despite President Donald Trump's criticism and Israel's threats. He has a hard-liner's pedigree, but will his tenure be confrontational, or aimed at broadening internal support for the regime? Also: today's stories, including why oil prices spiked to near $120 per barrel Monday before retreating below $100; why 17 candidates are competing in Tuesday's special election for Georgia's 14th Congressional District; and why Balendra Shah is on track to become Nepal's next prime minister. Join the Monitor's Matthew Bell for today's news.

Trap Talk Reptile Network Presents All Monitor Talk w/ Vanessa Crutchfield LiveJOIN THE TRAP TALK FAM HERE: https://bit.ly/311x4gxFOLLOW & SUPPORT THE GUEST:  / nessa.georgia  Host: Kat Brown  / thereptilewhisperer  Co-Host: Brandon Van Hasten   / kathryn.brown.54379236  

In this episode, Steve Fretzin and Leah Miller discuss: Run your law firm like a business, not a hobby Use accurate financials to avoid hidden risks and overpayment Track key metrics and benchmarks for people, operations, and marketing Leverage metrics to make strategic growth decisions   Key Takeaways: Long-term growth requires regular attention to financials. Cash in the bank is not a strategy; data should guide hiring, marketing, and operational decisions. Bad bookkeeping masks problems and can cost in taxes. Early investment in a bookkeeper or financial team yields high ROI and clarity. Monitor payroll, operating costs, and marketing spend as percentages of revenue. Focus on trends over time and adapt to what works for your firm. Financial data informs hiring, marketing, and process improvements. Treat new hires as investments, plan for cash gaps, and track time spent on business development for accountability.   "If you're not paying attention to the dollars and you're not operational decisions based on the finances, you are not going to have that long-term, sustained growth that you're looking for as a lawyer in a firm." —  Leah Miller   Check out my new show, Be That Lawyer Coaches Corner, and get the strategies I use with my clients to win more business and love your career again.   Ready to go from good to GOAT in your legal marketing game? Don't miss PIMCON—where the brightest minds in professional services gather to share what really works. Lock in your spot now: https://www.pimcon.org/   Thank you to our Sponsor! Rankings.io: https://rankings.io/ Lawyer.com: https://www.lawyer.com/   Ready to grow your law practice without selling or chasing? Book your free 30-minute strategy session now—let's make this your breakout year: https://fretzin.com/   About Leah Miller: Leah N. Miller, MBA, is the founder and CEO of Firmly Profits, a firm providing fractional CFO and bookkeeping services to law firms across the United States. Starting her career as a paralegal, Leah rose to become a firm administrator and CFO at a personal injury law firm in Fort Myers, Florida, where she recognized the need for law firm owners to gain confidence in their finances. Passionate about helping attorneys achieve financial clarity and sustainable growth, she now leads a team dedicated to offering expert financial guidance, process improvement, and strategic planning for firms of all sizes. Outside of work, Leah teaches paralegal courses and enjoys spending time with her husband and three daughters in sunny Southwest Florida.   Connect with Leah Miller:   Website: https://firmlyprofits.com/ YouTube: https://www.youtube.com/@LNMFinancialServices/videos LinkedIn: https://www.linkedin.com/company/firmlyprofits/ Facebook: https://www.facebook.com/people/LNM-Financial-Services/100091343407958/ Instagram: https://www.instagram.com/leah_lnm_financial/   Connect with Steve Fretzin: LinkedIn: Steve Fretzin Twitter: @stevefretzin Instagram: @fretzinsteve Facebook: Fretzin, Inc. Website: Fretzin.com Email: Steve@Fretzin.com Book: Legal Business Development Isn't Rocket Science and more! YouTube: Steve Fretzin Call Steve directly at 847-602-6911   Audio production by Turnkey Podcast Productions. You're the expert. Your podcast will prove it. 

The Government is actively monitoring the impact international fuel prices are having on the price we're being asked to pay at the pump. Crude oil prices have topped $100 US dollars a barrel for the first time in three years - and our petrol prices surged another 14 cents in the weekend. Finance Minister Nicola Willis says the Government's working with key industries to keep an eye on prices, in case there's a global shock. "We can assure New Zealanders that there's enough fuel for at least 60 days, and then beyond that - of course, fuel companies will be responsible for having their own orders in." LISTEN ABOVESee omnystudio.com/listener for privacy information.

Die minister van gesondheid sê sanitêre doekies bly veilig om te gebruik. Die parlement verdedig die reuse salarisverhoging van sy sekretaris. OUTA sê beter toesig is nodig oor NSFAS se bestuur van studenteverblyf. 'n Nuwe opperleier vir Iran.

Read transcriptIf you've ever dreamed of piloting a transforming jet while sorting through a love triangle and dodging alien laser fire, then without knowing it you've been living in the Robotech: The Macross Saga timeline. Chris dusts off his Game Boy Advance for this one, only to find that the same intergalactic mess has crash-landed again, this time in crisp Switch resolution. Because nothing says “future of gaming” like revisiting a handheld title from an era when batteries were a personality trait. Helping navigate this space-time crossover is DC Dave from The Monitor Tapes, swooping in with the kind of insight only a seasoned comic podcaster can offer. Together, they dissect what happens when '80s anime melodrama meets early 2000s portable gaming. And spoiler alert: there are missiles, misunderstood heroes, and at least one existential crisis per level. And yes, they both have Opinions™ about which version of Rick Hunter handles better. So grab your nearest mecha (or whatever piece of furniture doubles as one), set your thrusters to “nostalgia,” and dive into a world where pixelated warfare meets the stirring strains of synth-pop destiny. Whether you're a die-hard Robotech purist, a Switch newcomer, or just here for DC Dave's hot takes, this episode's got something for every flavor of space soap enthusiast. Learn such things as: What does it takes to make a side-scrolling shooter feel like an interstellar soap opera? How did licensing rights in the '80s created a cosmic headache that still echoes today? When you have giant fighting robots, do you really need to add all of the war allegory? And so much more! You can find DC Dave on BlueSky @dcdavepodcast, and of course under his podcast The Monitor Tapes on BlueSky @themonitortapes. If you want to be a guest on the show please check out the Be a A Guest on the Show page and let me know what you're interested in. If you want to help support the show check out the Play Comics Patreon page or head over to the Support page if you want to go another route. You can also check out the Play Comics Merch Store. Play Comics is part of the Gonna Geek Network, which is a wonderful collection of geeky podcasts. Be sure to check out the other shows on Gonna Geek if you need more of a nerd fix. You can find Play Comics @playcomics.bsky.social on Bluesky, @playcomicspodcast on Threads, @playcomics on YouTube, or the Play Comics website. If you want to hear Chris talk with Karrington Martin about the lessons we learned from children's media and how crazy it is that we're supposed to just forget about that now that we're adults, then Sugar, Spite, and Everything is Fine is probably something you should check out. A big thanks to Is It Jaws? and Capes on the Couch for the promos today. Intro/Outro Music by Backing Track, who refuses to acknowledge the passage of time and how what it means to any of us on a metaphysical level. Support Play Comics by contributing to their tip jar: https://tips.pinecast.com/jar/playcomics Check out our podcast host, Pinecast. Start your own podcast for free with no credit card required. If you decide to upgrade, use coupon code r-89f00a for 40% off for 4 months, and support Play Comics.

Once again, a crisis in the Middle East has the U.S. appealing for military help from the stateless Kurds, this time as boots-on-the-ground proxies in Iran. Affecting any desire to contribute is the memory of letdowns after vital roles played in Iraq and Syria. Also in today's stories: why Kristi Noem lost President Trump's trust; how war in Iran adds to existing strains on U.S. employment; and contributor Murr Brewster shares her enduring love of libraries. Join the Monitor's Stephanie Hanes for today's news.

(The Center Square) – Chicago Police say they are monitoring the U.S. conflict in Iran. Residents and visitors observed a significant increase in police presence at O'Hare International Airport and on area passenger trains this week. In a statement to The Center Square, the Chicago Police Department said it is monitoring the situation in Iran. “While there is no actionable intelligence related to Chicago at this time, we are paying special attention to places of worship and will adjust resources if necessary as we continue to follow the rapidly unfolding events,” the CPD statement said. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

The U.S. and Israeli leaders have made it clear they want regime change in Iran. But the Islamic Republic had prepared for this day, with a political succession plan and a battlefield strategy. The result so far is Iranian confidence, despite the existential threat of the war. Also: today's stories, including how the Iran conflict is generating criticism from many prominent MAGA commentators; why the U.S. is blocking oil shipments to Cuba; and how some Democrats seek to reclaim a moderate version of Christianity to attract voters they've lost to Republicans. Join the Monitor's Matthew Bell for today's news.

"The disease is increasingly managed as a chronic condition rather than a diagnosis with an immediate terminal outcome. Particularly, with earlier and more effective and sustained treatment options, we can make this disease a very chronic, long-term, livable condition. I want to make sure that patients are aware that this is not a death sentence. This is something that patients can live with for the long term," Ann McNeill, RN, MSN, APN, nurse practitioner at the John Theurer Cancer Center at Jersey Shore University Medical Center in Neptune, NJ, told Lenise Taylor, MN, RN, AOCNS®, TCTCN™, oncology clinical specialist at ONS, during a conversation about long-term multiple myeloma considerations for oncology nurses. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by March 6, 2027. Ann McNeill is on the speakers' bureau for Pfizer. This financial relationship has been mitigated. All other planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to management of long-term side effects related to multiple myeloma and treatment. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ episodes: Episode 401: Multiple Myeloma Treatment Considerations for Oncology Nurses Episode 398: An Overview of Multiple Myeloma for Oncology Nurses Episode 339: A Lesson on Labs: How to Monitor and Educate Patients With Cancer Episode 201: Which Survivorship Care Model Is Right for Your Patient? ONS Voice articles: Effective Care Transitions Are Essential for New Multiple Myeloma Treatments Infection Prevention for Oncology Nurses Multiple Myeloma Prevention, Screening, Treatment, and Survivorship Recommendations Nurse-Led Survivorship Programs Sexual Considerations for Patients With Cancer Oncology Nursing Forum articles:  A Qualitative Study of the Experiences of Living With Multiple Myeloma Changes in Health-Related Quality of Life During Multiple Myeloma Treatment: A Qualitative Interview Study ONS book: Multiple Myeloma: A Textbook for Nurses (third edition) ONS Huddle Cards: Pain Management Sexuality Survivorship Care Plan ONS Learning Libraries: Hematology, Cellular Therapy, and Stem Cell Transplantation Survivorship ONS Symptom Intervention resources: Chronic Pain Fatigue Peripheral Neuropathy American Cancer Society: Living as a Multiple Myeloma Survivor Blood Cancer United: Resources for Healthcare Professionals International Myeloma Foundation: Resources and Support for the Myeloma Community Multiple Myeloma Research Foundation: Empower Patients and the Community To discuss the information in this episode with other oncology nurses, visit the ONS Communities.  To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "We do consider myeloma an incurable hematologic malignancy, even though we have had improvements in survival. But just like for any malignancy, our goal is to maximize survival. We want to eliminate as many myeloma cells as we possibly can. And subsequently, we want to improve the quality of life for these patients in the long term. So those are basically our treatment goals. That's what we think of when we're treating patients all throughout their treatment journey." TS 1:39 "It is very typical for patients along their journey to have received several lines of therapy. I think it's important to realize that the cells acquire new mutations, making them more resistant to these further subsequent lines of therapy. We see quicker, more aggressive relapses in those patients with multiple prior lines of therapy. We can see an increase in the CRAB symptoms, which are the calcium elevations, the renal dysfunction, profound anemia, and even bone disease. We can see a rapid rise in the monoclonal protein in the labs or even a very rapid rise in the involved light chain in that serum free light chain assay, so it's important to monitor these labs." TS 9:14 "All oncology nurses are focusing on these survivorship plans now. And I think that's a great thing when you think about a diagnosis of cancer and a survivorship plan, because it means these patients are living a longer time. We still look at long-term health maintenance guidelines depending on the patient's sex and their age. ... I think preventing infection is always going to be something absolutely on the forefront in our survivorship plan with myeloma. I mean, myeloma is an immune system malignancy. The treatments that we have given patients can sometimes, especially in later life therapies, further compromise the immune system. So, we're always looking to prevent serious infection." TS 12:46 "Patients get treatment, especially induction therapy. They may or may not get transplant. They may have been on a very minor maintenance schedule, depending on their age. And they feel really well. And then they decide not to return for their follow-up because they feel so good. I think nurses are critical in the communication aspect of the patient-provider aspect. So, nurses are really the key means of communication. The providers are absolutely important—the physicians, the nurse practitioners and every other member of the team—but I think the nurses have a really special rapport with patients. They're usually the ones providing the education on the treatment regimens. They're managing the toxicity profiles. They're doing all the coordination of care between visits. They are really going to be the ones telling the patient, 'Hey, you're going to feel good and that's a wonderful thing, but you still need to come once a month or once every six weeks or once every two months for your labs.'" TS 15:17  "It has been amazing. The science, the research, the treatments, the approvals from the U.S. Food and Drug Administration. Survivorship has improved dramatically. Let's take the first few years of the new century, right? The five-year survival rate was about 38%. If you then jump to 2015–2019, which is still seven plus years ago, it has doubled. So, we're talking about anywhere from 60%–80% over a five-year survival. So that's an amazing improvement in their five-year survival rate for myeloma." TS 23:28 "Survivorship in myeloma begins at diagnosis, not just after treatment. And I think that because it is managed as a chronic, often relapsing disease, it does require lifelong evolving care. Patients should realize that they will know us for the rest of their lives. We will know everything about you. I always tell them, 'I will know everything about your hobbies, your children, your grandchildren, what you love to do on the weekends.' It's very important that that point is made right at diagnosis, not just after so many lines of treatment. It's very important that we are going to follow these patients throughout their journey." TS 28:18

Urgent Fraud Message: Stay Alert and Vigilant Against New Scam Tactics When conflict happens in the world, the effect can spread in ways beyond the immediate active zone. Times of turmoil often create opportunities for scammers to take advantage of unsuspecting victims due to fear, confusion, or panic. An increase in tensions has been known to boost fraud activity, making it imperative that you keep your guard up now more than ever.   Links: If you suspect fraud activity, contact Triangle Member Services Stay up to date on Fraud Alerts  Check out TCU University for fraud tips and resources! Follow us on Facebook, Instagram and Twitter! Learn more about Triangle Credit Union This is an urgent fraud message from the Making Money Personal podcast  Due to the ongoing conflict involving Iran and heightened global tensions, cybersecurity experts are warning that scammers may attempt to take advantage of the situation to target individuals and financial institutions. During times of international conflict, cybercriminals often increase phishing emails, fraudulent messages, and other online scams designed to trick people into sharing personal or financial information.   Our credit union wants to remind members to remain vigilant and take extra precautions when receiving unexpected emails, text messages, or phone calls—especially those claiming to be related to international events, government programs, financial relief, or urgent security alerts.  We can't stress it enough that you keep your guards up, so you don't fall for any of these scams. Some of the common ones to watch for may include:  Emails or text messages pretending to be from your financial institution asking you to “verify” your account information. Messages with links claiming to provide urgent updates about the conflict or financial markets. Fraudulent donation requests claiming to support humanitarian efforts. Phone calls pretending to be from banks, government agencies, or law enforcement requesting personal or financial information.    How to protect yourself:  Do not click links or download attachments from unknown or suspicious messages. Never provide your online banking credentials, passwords, or verification codes to anyone. Verify suspicious communications by contacting your financial institution directly using official contact information. Monitor your accounts regularly and report any suspicious activity immediately.     Our credit union will never ask for your password, PIN, or full account details through email, text, or unsolicited phone calls.  If you believe you have received a suspicious message or may have been targeted by a scam, please contact our Member Services team immediately.  Your security remains our top priority.  Please share this important message with your friends and family as a reminder to stay alert and guard against today's dangerous and sophisticated scams.        To stay up to date on news or important updates regarding scams, follow us on social media and visit our website trianglecu.org. Also, for more fraud awareness education and identity protection resources visit TCU university at triangleuniversity.org.  Thanks for tuning in to this very important message.  Stay alert and stay safe everyone! 

'n Teen-korrupsie forum gestig om korrupsie en misdaad in die watersektor te stuit. Nóg dosisse entstof teen bek-en-klouseer het in die land aangekom, maar bereik dit wel boere? Die voormalige minister, Naledi Pandor, se uitsprake oor Suid-Afrika se migrasiebeleid ontlok kritiek.

I spent an afternoon at Ramsey Solutions in Tennessee with Jason Williams, Vice President of Sales for the EntreLeadership Division. What stood out wasn’t the size of the operation or the fancy building. It was walking into a room where sales reps genuinely wanted to talk to their leader. Most sales floors feel like number factories. Reps avoid their managers. One-on-ones get rescheduled. And everyone wonders why performance stays flat despite “investing in our people.” Sales leaders say coaching matters. They talk about developing talent. Then they spend their days staring at dashboards and asking why the team isn’t getting better. Real sales coaching looks nothing like what most organizations call coaching. And after watching Jason work, I’m reminded why so few leaders actually get this right. What Sales Coaching Actually Looks Like Jason told me about one of his reps who started missing quota. Here’s what usually happens: Manager pulls up the CRM, points at red pipeline metrics, asks what happened. The conversation goes nowhere. Rep gets defensive, makes excuses, promises to work harder. Nothing changes. Jason took a different approach. He asked about his rep’s life. Turned out he was stressed about buying his first house. That weight was bleeding into his work, affecting his confidence on calls, making him hesitant to push for commitments. So Jason got into the field with him. He listened to calls. He rode along on appointments. He watched where deals were actually stalling. Then they debriefed what he observed. “Here’s what happens when pricing comes up.” “Let’s tighten how you handle that objection.” Zero mention of quota or pipeline metrics. The rep turned it around because someone cared enough to understand what was broken and help him fix it. That’s what coaching looks like. Managers react to outcomes they can’t change. Coaches focus on behaviors that create future outcomes. Why Most Leaders Don’t Coach The biggest barrier isn’t that leaders don’t want to coach. Most genuinely do. The problem is they don’t know what they’re looking for because they never see their reps in action. Think about last week. How many discovery calls did you listen to? How many demos did you observe? How many customer meetings did you attend just to watch your rep work? If the answer is zero, you’re coaching from spreadsheets instead of reality. You’re looking at lag indicators (closed deals, pipeline value, activity counts) and trying to diagnose skill gaps without ever seeing the skills in action. Jason blocks time every week to observe his reps. He's not there to supervise them or take over calls. Just to watch. Then the coaching becomes specific. He can say, “when that prospect brought up budget concerns, you deflected instead of asking questions,” instead of just “you need to handle objections better.” You can’t coach what you don’t see.  The second barrier is culture. In typical organizations, admitting weakness feels dangerous. You’re supposed to be confident, crushing it, always having answers. So problems stay hidden until they show up in the numbers. By then, it’s too late to coach. You’re in damage control. Creating an Environment Where Problems Surface Early Jason builds what he calls a “safe space” for his team. When a rep is struggling, he starts the conversation with curiosity instead of judgment. He asks open questions about what they’re experiencing, where they’re getting stuck, what feels hard right now. When reps admit struggles, he treats it as useful information, not a character flaw. A rep says, “I’m nervous on C-suite calls,” and Jason’s response is “okay, let’s work on that,” not “you shouldn’t be nervous.” Then he follows through. If someone admits they’re stuck, he actually helps them. He role-plays the situation. He rides along on the next similar call. He provides tools and frameworks. The rep sees that honesty led to help, not punishment. Over time, reps learn that surfacing problems early gets them solved. Hiding problems just makes things worse. So they start talking about what’s actually happening instead of pretending everything is fine while their numbers slide. The first time someone admits a weakness and you respond with frustration, you train the entire team to stay quiet. Managers say they want transparency. Few consistently reward it. How to Actually Build a Coaching Culture If you want to coach instead of manage, you have to make developing people the primary job.  Jason is clear that his main responsibility is making his reps better. Everything else supports that goal. Pipeline reviews and forecasting matter, but they exist to serve sales coaching, not the other way around. Protecting coaching time is non-negotiable. One hour per rep per week, minimum. When conflicts come up, the internal meeting gets moved, not the coaching session. Getting better at coaching matters too. Most of us got promoted because we were individual contributors. Nobody taught us how to develop other people. So we replicate whatever leadership we experienced, which is usually mediocre. Your reps practice selling every day. You should practice coaching. Role-play difficult conversations with your peers. Practice giving feedback. Work on observation skills. Treat coaching like the professional skill it is. And you have to measure what matters. If you only track team revenue, you’ll optimize for short-term numbers at the expense of development. Start measuring coaching conversations. Track whether your reps are improving on specific skills. Monitor how long it takes new hires to ramp. When I walked through Ramsey Solutions that day, I could feel the difference. Reps weren’t avoiding their leader. Retention was better. Performance was compounding over time instead of bouncing around based on whoever happened to be hot that quarter. What Happens Next Look at your calendar from last week. How much time did you spend observing your reps versus reviewing their numbers? How many true coaching conversations did you have versus pipeline reviews? If that ratio doesn't reflect what you say your priorities are, you've found the gap. Your reps don't need another dashboard. They need a leader who sees the work, understands where it's breaking down, and knows how to help them improve. Sales coaching isn't reacting to results. It's shaping the behaviors that create them. The question is whether you're willing to make that your real job. — Ready to build a stronger sales team? Download our FREE Small Business Guide to Sales Training and get the framework for developing high-performing reps.

Gulf Arab states lobbied hard for the United States to engage in talks with Iran. Yet in the war, 1,800 Iranian missiles and drones have been intercepted in Gulf airspace, with hundreds breaking through. The Gulf is being transformed by conflict. Will that last? Also: today's stories, including how America's recent strikes on Iran have underscored the task of ensuring the safety of U.S. citizens abroad during the escalating conflict; a look at the results of Texas' primary elections, and what lies ahead for the candidates; and how, in Nepal, the country's first elections since protests overthrew the government are a reason for some youth to stay. Join the Monitor's Ira Porter for today's news.

Though war news may continue to dominate, investors are also focused on Friday's February jobs report and yesterday's Broadcom results. Productivity and monthly layoff data loom. Important Disclosures This material is intended for general informational purposes only. This should not be considered an individualized recommendation or personalized investment advice. The investment strategies mentioned may not be suitable for everyone. Each investor needs to review an investment strategy for his or her own particular situation before making any investment decisions. The Schwab Center for Financial Research is a division of Charles Schwab & Co., Inc. All names and market data shown above are for illustrative purposes only and are not a recommendation, offer to sell, or a solicitation of an offer to buy any security. Supporting documentation for any claims or statistical information is available upon request. Past performance is no guarantee of future results. Diversification and rebalancing strategies do not ensure a profit and do not protect against losses in declining markets. Indexes are unmanaged, do not incur management fees, costs, and expenses and cannot be invested in directly. For more information on indexes, please see schwab.com/indexdefinitions. The policy analysis provided by the Charles Schwab & Co., Inc., does not constitute and should not be interpreted as an endorsement of any political party. Fixed income securities are subject to increased loss of principal during periods of rising interest rates. Fixed income investments are subject to various other risks including changes in credit quality, market valuations, liquidity, prepayments, early redemption, corporate events, tax ramifications, and other factors. All expressions of opinion are subject to change without notice in reaction to shifting market, economic or political conditions. Data contained herein from third party providers is obtained from what are considered reliable sources. However, its accuracy, completeness or reliability cannot be guaranteed. Investing involves risk, including loss of principal, and for some products and strategies, loss of more than your initial investment. Digital currencies [such as bitcoin] are highly volatile and not backed by any central bank or government. Digital currencies lack many of the regulations and consumer protections that legal-tender currencies and regulated securities have. Due to the high level of risk, investors should view digital currencies as a purely speculative instrument. Cryptocurrency-related products carry a substantial level of risk and are not suitable for all investors. Investments in cryptocurrencies are relatively new, highly speculative, and may be subject to extreme price volatility, illiquidity, and increased risk of loss, including your entire investment in the fund. Spot markets on which cryptocurrencies trade are relatively new and largely unregulated, and therefore, may be more exposed to fraud and security breaches than established, regulated exchanges for other financial assets or instruments. Some cryptocurrency-related products use futures contracts to attempt to duplicate the performance of an investment in cryptocurrency, which may result in unpredictable pricing, higher transaction costs, and performance that fails to track the price of the reference cryptocurrency as intended. Please read more about risks of trading cryptocurrency futures here. The Schwab Center for Financial Research is a division of Charles Schwab & Co., Inc. Apple Podcasts and the Apple logo are trademarks of Apple Inc., registered in the U.S. and other countries. Google Podcasts and the Google Podcasts logo are trademarks of Google LLC. Spotify and the Spotify logo are registered trademarks of Spotify AB. (0131-0326) Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Longford Libraries has announced the launch of a new Radon Monitor Loan Scheme, enabling members of the public to borrow digital radon monitors to check radon levels in their homes. The initiative forms part of the national Healthy Ireland at Your Library programme and is supported by the Environmental Protection Agency (EPA). Radon is a naturally occurring radioactive gas that can accumulate indoors. It is the second leading cause of lung cancer in Ireland after smoking. Testing is the only way to know if radon is present in a home. Through this scheme, library members in both Ballymahon and Granard Libraries can borrow a digital radon monitor just like a book, allowing them to gain a snapshot reading of radon levels in their homes. While the monitors do not replace the recommended three-month radon test, they provide a valuable first step in identifying potential radon issues and raising awareness. County Longford County Council Cathaoirleach Cllr Garry Murtagh said, "Longford County Council is proud to support this initiative as part of our wider commitment to public health and community wellbeing. By making radon monitors freely accessible through our library service, we are ensuring that residents have practical tools and reliable information to safeguard their homes and families. This initiative reflects the evolving role of our libraries as accessible, trusted community spaces delivering real and meaningful supports." Deputy Chief Executive of Longford County Council, John Brannigan said, "Longford Library Services is committed to supporting our community in practical and meaningful ways. Libraries today are vibrant community hubs offering far more than traditional book lending. This Radon Monitor Loan Scheme is an important health initiative that empowers people to take proactive steps to protect their wellbeing. We encourage everyone to avail of this free service." The initiative has already seen success in several counties and is now being rolled out in additional library services nationwide. The EPA has supported the scheme by providing monitors, staff training and promotional materials. Chair of the National Healthy Ireland at Your Library Working Group, Amanda Branigan, said, "This scheme demonstrates how libraries can play a vital role in delivering national health initiatives at a local level. From literacy and lifelong learning to health and wellbeing supports, libraries continue to evolve to meet community needs. Making radon monitors available to borrow is another example of how libraries help people make informed decisions about their health." For more information about radon testing, visit www.radon.ie. For further details about the Radon Monitor Loan Scheme, contact your local Longford Library branch or visit www.longfordlibrary.ie. See more stories here.

Brendan! is on edge early in this episode ahead of a win-and-in Jupiter Links match rounding out TGL's regular season. He shares his favorite team's lineup for the match with Andy and highlights management's decision to send out Kevin Kisner for this pivotal moment in team history. Things quickly transition into the Schedule for the Week for another loaded weekend of outdoor golf. The PGA Tour returns to Bay Hill Club & Lodge for the Arnold Palmer Invitational, one of the premier iron tests on the schedule. Brendan claims that you "cannot be a fraud" this week and believes imposters will be exposed around Arnold's Place. Andy's "5 Guys to Monitor" puts the spotlight on two players making their first PGA Tour starts of 2026 and some other big-name players searching for a win in Florida. There are some laments from Andy about the smaller, Signature Event field making Bay Hill not as fun for PGA Tour Live viewing, but Brendan pushes back and is excited to see all the screened-in porches. PJ jumps in to run the year's first installment of In/Out/Alternate in honor of this week's Puerto Rico Open, where the Past Champions category is putting in work after a slew of withdrawals. Ben Crane's much-anticipated (and highly bet on!) Champions Tour debut is blown by in the rundown in favor of a discussion about Jon Rahm's comments in Hong Kong. Many LIV players are stuck in the Middle East and reserves will be in action, but Rahm made the trip and decided to prolong his fight with the DP World Tour. He has taken exception to the DP World Tour mandating that LIV members play six events, making for a busy fall following the LIV season's end. Andy and Brendan do not feel any pain for Rahm, wondering how he's gone this far in his "delusional" fight against the DPWT. Will this mark the end of Rahm's Ryder Cup career? It looks like things are trending that way. Use promo code SGS30 to shop the Draddy Sport Spring collection: ⁠https://bdraddy.com/collections/draddy-sport-spring-26-collection

For many Iranian opponents of the regime, news of the supreme leader's death at the start of the new war brought elation. But, says a Tehran student who risked his life in protests before the war, there are concerns that the job of regime change is incomplete. Also: today's stories, including how the U.S.-Israeli attacks on Iran are sending political ripples through Congress; a look at how a partial U.S. government shutdown is affecting TSA; and how China is engaged in a huge nuclear weapons expansion, growing the size and capabilities of its arsenal. Join the Monitor's Christa Case Bryant for today's news.

Die GOOD-party het Sandra Dickson gevoeg as raadslid in sy Koukus van Aktiviste in die Stad Kaapstad. Sy vervang Anton Louw, wat bedank het om op sy rekeningkundige praktyk te fokus. GOOD se sekretaris-generaal, Brett Herron, sê Dickson se sterkpunt oor die jare was om fondse noukeurig te monitor, en haar formele opleiding in die finansiële sektor en liefde vir wiskunde aan te wend vir die bevordering van maatskaplike geregtigheid:

Airstrikes against Iran were effective in the early days of the mission. But there's more to do – both offensively and defensively – if the U.S. hopes to crack Iran's regime. Also: today's stories, including what's at stake for global oil prices as the Iran conflict escalates; a look at a hardball battle for the Republican U.S. Senate nomination in Texas; and how Mexico's diplomatic support to Cuba has long boosted the communist island. Join the Monitor's Kurt Shillinger for today's news.

In this conversation, Jeff Sarris and Jill Harris discuss the implications of protein powders for kidney stone formers, exploring both the benefits and potential risks associated with their use. They delve into the importance of understanding oxalate levels in protein powders, the role of artificial sweeteners, and the necessity of maintaining a balanced diet. Jill emphasizes the need for dietary flexibility and the importance of whole foods while also providing insights into healthy protein options and meal replacements.https://kidneystonediet.com/pros-and-cons-of-protein-powders/TakeawaysProtein powders can be beneficial but have risks.High oxalate levels in some protein powders can cause issues.Artificial sweeteners can be used in moderation.Dietary flexibility is key for long-term success.Collagen protein can convert to oxalate, avoid it if prone to stones.Protein shakes should not replace real meals.Focus on whole foods for better nutrition.Monitor sodium levels in protein powders.Healthy protein options exist for kidney stone formers.Diverse recipes can help maintain a balanced diet.00:00 The Truth About Protein Powders00:18 Pros and Cons of Protein Powders05:10 Artificial Sweeteners and Kidney Stones09:23 Dietary Flexibility and Lifestyle Changes12:19 Collagen and Meal Replacements14:12 Healthy Protein Options and Conclusion——When you're ready, here's how I can helpSince 1998, I've helped thousands of patients prevent kidney stones. With my Kidney Stone Diet All-Access Pass, you get access to every prevention tool I've ever created:Weekly Kidney Stone Diet Meal Plans​4 meals per day, 7 days per weekWeekly Kidney Stone Prevention Group Consultations3 video calls per week with me and the Kidney Stone Diet communityAll of my Kidney Stone Diet EbooksLow Oxalate Protein Bars, Kidney Stone Safe Smoothies, Kidney Stone Safe Snacks & Desserts, and the Low Oxalate CookbookPlus, 20% Off Private ConsultationsAnd, as a BONUS, you'll get my flagship Kidney Stone Prevention Course (normally $249) absolutely free!LEARN MORE!——WHO IS JILL HARRIS? _Since 1998, Jill Harris has been the #1 kidney stone prevention nurse helping patients prevent kidney stones. Drawing from her work with world-renowned University of Chicago nephrologist, Dr. Fred Coe, and the thousands of patients she's worked with directly, she created the Kidney Stone Diet®. With a simple, self-guided online video course, meal plans, cookbooks, group consultations, and private consultations, Kidney Stone Diet® is Jill's effort to help as many patients as possible prevent kidney stones for good.

As we close out American Heart Month on Full Circle, this episode centers on a story that is both heartbreaking and life-affirming.Marvale Young has always been a caregiver. A devoted mother, she fostered more than 30 children, opening her home and heart to young people who needed stability, love, and safety. She was the strong one — the one who carried others through their storms.But over time, life carried its own weight. After losing her husband and navigating years of emotional stress, Marvale began noticing subtle shifts in her health. Fatigue. Changes in her body. Signals that were easy to overlook when you are used to putting everyone else first.Then came the diagnosis: heart failure.In this intimate conversation, Marvale reflects on what it felt like to hear those words and whether prolonged stress and unresolved grief contributed to her declining health. Caregivers often ignore their own needs. Women, especially, push through discomfort. Marvale's story challenges us to reconsider that pattern.And then — in the midst of unimaginable grief, just days after losing her son — she received a call that would change everything. A donor heart was available.Her journey from heart failure to transplant is a powerful reminder of the lifesaving impact of advanced cardiac care, organ donation, and medical research. It is also a testament to resilience, faith, and the gift of second chances.Heart disease remains the leading cause of death in the United States. Symptoms are often subtle. Stress is not “just stress.” Fatigue is not always “just being tired.”This episode is about listening to your body before it whispers become emergencies.Call to Action:Make your heart health a priority. Schedule a physical. Monitor your blood pressure. Have honest conversations about stress, grief, and self-care. Learn how you can support heart health education and survivor advocacy through the American Heart Association. Share Marvale's story — it could inspire someone to seek care sooner.

Confira os destaques do Jornal da Manhã desta segunda-feira (02): O governo brasileiro prestou solidariedade a países impactados por ataques retaliatórios do Irã e pediu a interrupção de ações militares na região do Golfo. Em nota divulgada na noite deste sábado (28), o Ministério das Relações Exteriores afirmou que a escalada representa uma grave ameaça à paz. Um ataque a tiros na madrugada deste domingo (1º) em Austin, capital do estado do Texas, deixou três mortos e 14 feridos. Entre as vítimas fatais está o próprio atirador, que foi confrontado e baleado por policiais. O Federal Bureau of Investigation (FBI) informou que investiga o caso como um “potencial ato de terrorismo”. Manifestação realizada na Avenida Paulista, em São Paulo, reuniu 20.400 pessoas, segundo o Monitor do Debate Político da Universidade de São Paulo (USP), o Cebrap e a ONG More in Common. O ato criticou o presidente Luiz Inácio Lula da Silva e os ministros Alexandre de Moraes e Dias Toffoli, do Supremo Tribunal Federal, além de defender anistia ao ex-presidente Jair Bolsonaro (PL). Em declaração neste domingo (1º), o Papa Leão XIV fez um apelo por paz e diálogo diante da nova escalada de violência no Oriente Médio. O conflito teve início após ataques realizados por Estados Unidos e Israel contra o Irã no último sábado (28). O primeiro-ministro de Israel, Benjamin Netanyahu, afirmou neste domingo (1º) que os ataques contra Teerã devem se intensificar nos próximos dias. Segundo ele, o exército israelense mobilizou “toda a sua força” na campanha militar contra o Irã. O Tribunal Superior Eleitoral retoma nesta segunda-feira (02) o julgamento das propostas de regras que serão aplicadas nas eleições deste ano. As medidas não alteram a legislação eleitoral vigente, mas detalham e regulamentam pontos já previstos em lei para garantir maior clareza na aplicação das normas. Apenas 27% dos norte-americanos declaram aprovar os ataques realizados pelos Estados Unidos em conjunto com Israel contra o Irã, iniciados no sábado (28). Segundo levantamento da Reuters em parceria com o Ipsos, 43% desaprovam a ofensiva, enquanto 30% preferiram não responder. O governo iraniano afirmou nesta segunda-feira (2) ter atacado o gabinete do primeiro-ministro de Israel, Benjamin Netanyahu, segundo afirmou a agência de notícias AFP. A escalada do conflito envolvendo Estados Unidos, Israel e Irã pode provocar mudanças profundas na geopolítica internacional. O ex-embaixador do Brasil em Washington, Rubens Barbosa opinou. As Forças de Defesa de Israel iniciaram nesta segunda-feira (02) uma operação aérea em larga escala com ataques simultâneos no Irã e no Líbano. O general Effie Defrin confirmou que centenas de aviões foram mobilizados para neutralizar alvos considerados estratégicos. A gigante estatal de petróleo Saudi Aramco interrompeu temporariamente as operações de sua refinaria em Ras Tanura, uma das maiores do mundo, após um ataque com drone na madrugada desta segunda-feira (2), no contexto da escalada de violência no Oriente Médio. O Partido Democrata nos Estados Unidos enfrenta um impasse diante dos ataques contra o Irã. Parte das lideranças defende uma postura firme em política externa ao lado de aliados tradicionais, enquanto outra ala teme os impactos eleitorais. Essas e outras notícias você acompanha no Jornal da Manhã. Learn more about your ad choices. Visit megaphone.fm/adchoices

Welcome to The Daily Wrap Up, an in-depth investigatory show dedicated to bringing you the most relevant independent news, as we see it, from the last 24 hours (2/28/26). As always, take the information discussed in the video below and research it for yourself, and come to your own conclusions. Anyone telling you what the truth is, or claiming they have the answer, is likely leading you astray, for one reason or another. Stay Vigilant. !function(r,u,m,b,l,e){r._Rumble=b,r[b]||(r[b]=function(){(r[b]._=r[b]._||[]).push(arguments);if(r[b]._.length==1){l=u.createElement(m),e=u.getElementsByTagName(m)[0],l.async=1,l.src="https://rumble.com/embedJS/u2q643"+(arguments[1].video?'.'+arguments[1].video:'')+"/?url="+encodeURIComponent(location.href)+"&args="+encodeURIComponent(JSON.stringify([].slice.apply(arguments))),e.parentNode.insertBefore(l,e)}})}(window, document, "script", "Rumble");   Rumble("play", {"video":"v748wcq","div":"rumble_v748wcq"}); Video Source Links (In Chronological Order): Stephanie Seneff PhD Interview - Glyphosate & The Engineered Sick Care System Biotech and Pesticide Corporations Are "Winning" Under Trump's Second Administration New Tab (20) Monitor

For former President Bill Clinton, who left office 25 years ago, the impact of the Epstein scandal may only further damage his image, particularly among younger Democrats, amid changing mores around sexual misconduct by powerful men. Also: today's stories, including, how in Boston, a Monitor reporter set off to find out what cities do with an abundance of snow; how India has increasingly used cricket as an extension of its foreign policy with Pakistan; and how a contributing writer finds respite in his postcard pastime despite living in a digital world. Join the Monitor's Clay Collins for today's news.

We are celebrating National FFA week by sharing about famous past members to news of a new Florida invasive species, learn about Tigger auctioneering overseas plus what to know regarding international travel and tips to stay safe! Join radio hosts Rebecca Wanner aka ‘BEC' and Jeff ‘Tigger' Erhardt (Tigger & BEC) with the latest in Outdoors & Western Lifestyle News! Season 6, Episode 278 Famous FFA Alumni Who Shaped America The National FFA Organization has produced leaders in business, politics, science, and entertainment. FFA builds skills in leadership, public speaking, agriculture, and community service. Notable FFA Alumni Jeff “Tigger” Erhardt (Alumni and Honorary Chapter FArmer, FFA Livestock Judging Coach): National Radio Show Host, New Broadcaster, PRCA Announcer. 39th President Jimmy Carter Johnny Cash Charlie Daniels John Mellencamp Willie Nelson Don Henley of The Eagles George Strait Cody Johnson Tim McGraw Taylor Swift Bo Jackson (Sports Legend) Brantley Gilbert Trace Adkins Easton Corbin Chancey Williams Jim Davis - Creator of the Garfield comics! Lane Frost Tuff Hedeman Baxter Black Reference: https://ffa.app.box.com/s/6pe6an7rgm9c042tbkbobqc8tuu0o1hz South Florida Faces Growing Threat from Invasive Nile Monitors A new invasive predator is spreading in South Florida — and it's a big one. The Nile monitor, a six-foot-long lizard native to Africa, is gaining ground in parts of the state. Wildlife officials say the species poses a serious threat to native animals, and it can now be killed year-round without a permit. Known for tackling invasive reptiles, trapper Mike Kimmel — also called the Python Cowboy — describes the Nile monitor as “like a python mixed with an iguana.” They're powerful, intelligent predators, similar to a smaller Komodo dragon. On Florida's west coast, especially in Cape Coral, biologists have been battling the species for nearly 20 years. Hundreds have been trapped, but pockets remain. That's concerning because Cape Coral is also home to Florida's largest population of the threatened Burrowing owl, which nests in the ground — making it vulnerable to predators like the Nile monitor. These lizards are carnivores. They eat fish, frogs, birds, eggs, small mammals — even young crocodiles — and have been known to attack chickens and small pets. They can grow up to 6.5 feet long, weigh nearly 20 pounds, run up to 18 miles per hour, and swim underwater for nearly an hour. Their ability to travel along canals and waterways has helped them spread. The Florida Fish and Wildlife Conservation Commission is actively removing Nile monitors and urges residents to report any sightings. Wildlife officials warn: this is one invasive species South Florida can't afford to ignore. Reference: https://www.outdoorlife.com/conservation/florida-newest-invasive-nile-monitors/ What To Do To Minimize Stress About International Travel and “Shelter In Place” Warnings Last weekend Americans were told to shelter in place following a Mexican drug lord's death on Feb. 22, 2026. As a result, parts of Mexico have seen civil unrest in the wake of his death, including vehicles being torched and gunmen, believed to have supported the deceased, blocking highways in more than a dozen Mexico states. This is a great reminder that anytime traveling beyond the U.S. borders to utilize the Smart Traveler Enrollment Program (STEP), a free service to U.S. citizens and nationals to enroll a trip abroad so that the Department of State can accurately and quickly contact in case of emergency. Benefits of STEP Updates about health, weather, safety and security for your destination. Plan ahead using information from the local U.S. embassy. Helps the embassy or consulate contact you if there is an emergency like a natural disaster, civil unrest, or a family emergency. Current Status: According to the U.S. Embassy & Consulates in Mexico website. Actions to Take: Seek shelter and minimize unnecessary movements. Avoid areas around law enforcement activity. Check @CAPUFE on X for status of road closures. Monitor local media for updates. Follow the directions of local authorities and in case of emergency, call 911. Keep family and friends advised of your location and well-being via phone, text, and social media. How To Be Travel Prepared Traveling abroad: Register in the Smart Traveler Enrollment Program. Pack snacks such as microwave popcorn and small snacks. Stock your hotel room with extra bottled water and individually packaged snacks. Advise family and friends of location, length of trip and emergency contact information. Travel with extra medications as well as over the counter aides such as cold and fever meds. Philippines During this episode we learn how radio host, Jeff "Tigger" Erhardt", traveled to the Philippines for auctioneering. Tigger is a licensed and bonded auctioneer, with over 20 years experience. The Philippines was a new venture for Tigger and he shares in-depth the difference between American Auctions vs International and then selling Heavy Equipment in a foreign currency. Quick Philippines Travel Summary The Philippines are located in Southeast Asia, in the western Pacific Ocean and consist of over 7,100 islands. Positioned east of Vietnam and north of Indonesia. Capital: Manila Currency: Philippine Peso (PHP). Cash is king outside major cities. Language: Filipino and English Best Time to Visit the Philippines There are two main seasons. Dry Season: November–May (best time, especially Dec–April) Rainy Season: June–October (typhoons possible) Philippines Travel Tips Recommend drinking only bottled or filtered water. Street food is popular but choose busy vendors. Consider routine vaccines (consult your doctor). Sun protection is essential - climate is very humid and hot. OUTDOORS FIELD REPORTS & COMMENTS We want to hear from you! If you have any questions, comments, or stories to share about bighorn sheep, outdoor adventures, or wildlife conservation, don't hesitate to reach out. Call or text us at 305-900-BEND (305-900-2363), or send an email to BendRadioShow@gmail.com. Stay connected by following us on social media at Facebook/Instagram @thebendshow or by subscribing to The Bend Show on YouTube. Visit our website at TheBendShow.com for more exciting content and updates! https://thebendshow.com/ https://www.facebook.com/thebendshow WESTERN LIFESTYLE & THE OUTDOORS Jeff ‘Tigger' Erhardt & Rebecca ‘BEC' Wanner are passionate news broadcasters who represent the working ranch world, rodeo, and the Western way of life. They are also staunch advocates for the outdoors and wildlife conservation. As outdoorsmen themselves, Tigger and BEC provide valuable insight and education to hunters, adventurers, ranchers, and anyone interested in agriculture and conservation. With a shared love for the outdoors, Tigger & BEC are committed to bringing high-quality beef and wild game from the field to your table. They understand the importance of sharing meals with family, cooking the fruits of your labor, and making memories in the great outdoors. Through their work, they aim to educate and inspire those who appreciate God's Country and life on the land. United by a common mission, Tigger & BEC offer a glimpse into the life beyond the beaten path and down dirt roads. They're here to share knowledge, answer your questions, and join you in your own success story. Adventure awaits around the bend. With The Outdoors, the Western Heritage, Rural America, and Wildlife Conservation at the forefront, Tigger and BEC live this lifestyle every day. To learn more about Tigger & BEC's journey and their passion for the outdoors, visit TiggerandBEC.com. https://tiggerandbec.com/

President Donald Trump has issued executive orders on voting, and his administration is suing states that have refused to turn over voter rolls. Congress has taken up legislation that would require proof of citizenship for voter registration. Last month, the FBI raided an election center in Georgia as part of a criminal investigation into the 2020 election. Also: today's stories, including how students in Iran have courageously protested for days despite leadership claims; how in a politically red Texas, Democrats have hope in the upcoming primaries; and how the misconduct investigation into the former Prince Andrew is putting the British monarchy under a harsh glare. Join the Monitor's Linda Feldmann for today's news.

What if the reason you’re not healing isn’t that you need another diagnosis? 0:08 It’s that your cells aren’t receiving the right signals. Because the body doesn’t run on diagnosis, it runs on 0:16 communication. And peptides are one of the most powerful, most misunderstood 0:21 tools we have for cellular signaling, immune balance, tissue repair, gut 0:27 lining support, metabolic control, brain signaling, sleep cycles, and even sexual 0:35 wellness. Today, I’m going to do what most people won’t. Define peptides in 0:41 plain English for you. break them into categories by what they’re best at and 0:47 tell you which ones are FDA approved on the list and which ones are commonly 0:53 used off label or investigational with the evidence that actually says these 1:00 work. This is going to be a powerful episode and if you’ve ever felt like you’re hearing hype without clarity, 1:07 this one’s for you. So, as usual, grab your cup of coffee or tea and settle in 1:13 as we talk about peptides that can fit into your healing journey. We’re going 1:19 to have a short word from our sponsor. You know, we got to do that. That’s how we stay on the air here. So, we will be 1:26 right back after this. Did you know sweating can literally heal your cells? 1:32I nfrared saunas don’t just relax you. They detox your body, balance hormones, 1:37 and boost mitochondrial energy. I’m obsessed with my health tech sauna. And 1:42 right now, you can save $500 with my code at healthtechalth.com/drmuthqen25. 1:54 All right, here we go, guys. I am excited to dive into peptides with you. 2:00 So understanding peptides is foundational, right? And I’ve been 2:06 studying peptides now for about nine years. Um, and I find that they are 2:13 incredible. Um, so I want to break down for you what peptides actually are, what 2:19 they do, and some of the top peptides that are available today, and how they 2:25 can be utilized. Because I think it’s really important. And I think it’s it’s there’s a lot of confusion out there about what these things actually are and 2:32 are they safe? Are they not? When do we use them? What’s the science behind them? So, we’re going to dive in and 2:38 we’re going to talk about all things peptides. So, let’s get ready here. Here we go. So, peptides are short chains of 2:45 amino acids and they typically range anywhere from 2 to 50 amino acids and 2:51 they’re linked by peptide bonds. So think of them as the superglue that holds the amino acids together. They sit 2:58 between the amino acids and they are full proteins in terms of their size and 3:04 their complex structure. And what makes peptides particularly interesting in 3:10 medicine is their role as signaling molecules. They’re essentially the 3:15 body’s text messages carrying specific instructions to cells and tissues. And 3:21 unlike our proteins which often serve as structural roles or act as enzymes, 3:28 peptides typically function as hormones, neurotransmitters and growth factors and 3:33 they bind to specific receptors on the cell’s surfaces or within the cells and 3:39 they trigger this effect. It’s like a cascade effect of a biochemical reaction 3:45 that ultimately changes the cellular behavior. So basically, it’s changing 3:50 the way the body’s cell structure acts. And this is why peptides can be so 3:56 incredibly powerful and therapeutic when you introduce the right peptide signal. 4:02 Now, you could theoretically redirect cellular processes toward healing, 4:07 towards metabolism, immune balance, tissue repair. Any of those things can 4:14 be manipulated to do a certain thing once we add the peptide. The challenge 4:19 in peptide medicine though lies in distinguishing between those peptides that have been rigorously studied, 4:26 proven safe and effective and approved by regulatory bodies like the FDA versus 4:31 those that exist in what we call the gray zone of a promising clinical data. 4:36 But they really lack human validation so far. And this distinction is critical because the presence of a plausible 4:43 mechanism does not guarantee safety or efficacy in living humans. So, this is 4:50 really important and we’re going to dive in and look at some of the research on all of these different peptides that are 4:56 available and I’m excited to say there’s some amazing peptides being studied right now that unfortunately are not 5:01 available. But I can’t wait to see them hit the market for us because it is going to be a gamecher as far as health 5:09 and longevity. So there is a quality control issue and there is a hidden 5:14 variable in peptide medicine with this and it’s one of the most underappreciated aspects of peptide 5:21 therapy particularly for non-FDA approved peptides. It’s quality control. 5:26 When we discuss pharmaceutical medicines, we take for granted that the pill contains what the label says. Not 5:32 always true depending on where it comes from. You guys, if you’ve heard my episodes before talk about how many of our medications are made in China and 5:41 have been contaminated with other things, you will realize that that is not always true. So, just because it has 5:48 the FDA stamp of approval on the medication, it still does not necessarily mean it’s safe and we still 5:54 need to do our homework on it. So, sorry for digressing on you guys, but you know, when we get a medication, we we 6:00 think that what the amount says is what is there, doesn’t have contaminants, it’s manufactured with good 6:06 manufacturing practices. You’ll see that listed as GMP on the bottle, and it’s been stored properly, it’s been 6:12 maintained stable, and with research peptides and compounded formulations, 6:17 none of this can be assumed. So, I will share a story with you. There was a gentleman that was purchasing these 6:24 peptides online from a research facility and um did not know that they were 6:30 coming from China and he was ordering a particular growth hormone peptide and 6:35 after a little while he had he had done fine for the few first few bottles. After a little while he started having 6:42 some complications. He started getting really irritable and angry and ragy and 6:47 he didn’t quite know what was going on. And so he decided to go get some testing done. He had some blood testing done and 6:53 his testosterone level was over 5,000. So for those of you who know what testosterone level should be for a guy, 7:00 they really shouldn’t be any higher than about 1,00200 would be absolute max that we’d want to see. Now he was taking 7:06 testosterone but not to that degree. And prior to adding this peptide, his 7:12 testosterone was very stable. What they ended up finding out was the peptide that he was getting, whoever was 7:18 manufacturing it added testosterone to the peptide. They felt like if if it had growth hormone, that was great, but if 7:25 it had growth hormone and tes testosterone, all the better. And he didn’t know that. And this is the 7:31 problem that we can have with peptides if you don’t source them properly. if you’re not working with somebody that 7:37 knows how to source them and can prove that they are what they say they are. Um, I’m sure there’s a whole bunch of 7:42 studies out there too of people getting these peptides and paying hundreds of thousands of dollars for them over their 7:48 lifetime and finding out they were nothing more than just sterile water. So, you really do need to be careful 7:53 with your quality control. Now, this kind of leads us right into the next topic that we’re going to talk about and that’s the manufacturing question, 8:00 right? The FDA approved peptides are manufactured in facilities subject to 8:05 the FDA inspection rules following our GMP regulations and these facilities 8:11 must validate their manufacturing process, demonstrate consistency batch to batch, test for purity and potency. 8:18 They need to test for bacterial endotoxins and sterility and they need to maintain detailed records. So, when a 8:25 pharmaceutical company submits a drug application, the FDA inspects the manufacturing facility as part of the 8:32 approval process. If you’re getting peptides from a different country, none of that is happening. And there are some 8:38 ways for us to determine if that is what you’re getting. Typically, the rule of thumb is if your peptides are coming 8:44 with a different colored top, every one of them has a different colored top. Those are typically being sourced out of 8:49 China. I wouldn’t say that’s 100% but that’s kind of the rule of thumb that people follow. So compoundingies these 8:56 are thearmacies that make our bio identical hormones. They can make medications in any dose or strength or 9:02 route. There are thousands of them in every not that not in every state but 9:08 there are thousands of them around the country right now. So these compoundingies are registered as 503A 9:15 facilities. They do traditional compounding for individual prescriptions, right? Like they can make 9:20 thyroid, they can make LDN, they can make estrogen. You can also have a 503b 9:27 facility, which is an outsourcing facility. And these companies produce larger batches of products. They’re they 9:34 have some oversight, but they’re less stringent than for FDA approved 9:40 manufacturers. And state boards of pharmacy regulate a 503A pharmacy. And 9:45 the FDA can inspect the 503b facility, but doesn’t preapprove any of their 9:52 compounding products. So, they can inspect it, but they don’t approve them. So, research chemicals and these 9:58 suppliers operate essentially with no oversight. They explicitly market products for research use only, not for 10:06 human consumption to avoid FDA regulation. If they put that on their 10:12 product, they don’t have to comply to what the FDA is saying. And there is no required manufacturing strategies or 10:19 standards, no required testing, no required sterility assurance, and no enforcement mechanisms if products are 10:26 mislabeled or contaminated. So basically, they don’t have the liability, but that doesn’t mean that 10:31 all of them are badies or bad suppliers. It just means they don’t have to comply 10:37 to the FDA rules. Now, there are many of these companies that I’ve seen and I’ve talked to that do do a lot of this. They 10:44 do test their product for sterility. They do test their product to make sure it is what it says it is. They don’t 10:51 have to, but they do. So, if you’re going to decide to use a company that 10:56 has research only, not for human consumption, at least ask for their 11:02 proof of testing so that you know that the product you’re getting is what it says it is and that it’s clean. Because 11:08 this is where we run into the problem is in purity. So in purity peptide 11:13 synthesis can produce not just the targeted peptide but also related 11:19 peptides with deletions, substitutions, truncations or truncations of amino 11:25 acids. Sorry. And this high performance liquid we call it uh chromatography can 11:30 separate these related impurities and quality and quantify the actual target 11:35 of the peptide content. So a certificate of analysis is what you want to ask these companies for. This shows the HPLC 11:44 the testing mechanism with greater than 95% or ideally 98% purity which 11:51 indicates a higher quality product. So this certificate of analysis can be fabricated may not represent the 11:57 specific batch being sold. It happens. We need to know not everybody is honest. Not everybody, you know, does what they 12:03 say and it does what’s right. But at least you at least they’re giving you something and you have some security. 12:10 and then choose a company that was referred to by someone else that has done some homework as well. In in 12:16 commercial research, there’s independent testing and they research peptides and this has been really shocking 12:23 variability that they’ve seen. Some products contain 50% or less of the 12:29 claimed peptide and some contained primarily degradation of the product or manufacturing impurities and some 12:36 contained bacterial endotoxins at levels that could cause fever and systemic 12:42 inflammation if it was truly injected. And I would also worry with some of those problems, you know, depending on 12:48 what impurity or bacterial endotoxin was there. If you’re using a product to boost your immune system and your immune 12:54 system is already compromised, these bacterial endotoxins can actually make you sicker instead of what you want it 13:02 to do, which is making you better. So, sterility is always an issue with anything that is manufactured, 13:08 especially things that we’re doing as an injection. Peptides are intended for injection. They must be sterile. They 13:16 must be kept safe. And pharmaceutical manufacturers conduct this sterility testing on every batch. 13:22 Compoundingarmacies should conduct sterility testing particularly for high-risisk compounded 13:28 sterile preparations and research chemical suppliers may or may not conduct any testing. So injecting 13:35 non-sterile material can cause local infections, abscesses at the injection 13:41 site and or if the bacteria enters the bloodstream could potentially be 13:46 life-threatening and you could have sepsis. Now, excuse me. We saw this 13:52 happen in a compounding pharmacy uh gosh, it’s probably been 10 years ago 13:57 now, I think. um they unfortunately had a strep uh contamination in their 14:03 product and they weren’t testing it. It was a large compounding pharmacy out of Florida and they were making products 14:08 that were being injected into the joints and um these people got very very sick 14:14 and some of them died and um some of them got very very injured by this uh 14:21 complication that happened. So it’s not like this doesn’t happen. It does, but it doesn’t happen often. And that’s what 14:28 we have to know about. And so, when we’re talking with you guys about storage and stability, it’s really 14:34 important to make sure you maintain your peptides well. So, many peptides are unstable at room temperature. They 14:41 require refrigeration or freezing. We tell everyone to make sure you’re refrigerating your peptides. That way, 14:48 there’s no question about it. when it stays cold um it prevents or slows down 14:54 the process of uh bacteria growing in it. So some of these peptides actually 14:59 degrade very rapidly in the solution and they must be reconstituted immediately before use and reconstitution of the 15:07 peptides really has limited stability often just days to weeks not months. So 15:13 improper storage, temperature, um changes during shipping or prolonged 15:19 storage of a reconstituted product can lead to degradation into inactivity or 15:25 potentially even a harmful breakdown of the product itself. So if you have a product that’s been sitting in your 15:30 refrigerator for a month or two months or 3 months or 6 months, just throw it away. It’s not going to be any good. 15:37 you’re not going to actually get the peptide and the uh potency that you’re looking for anyway out of it and the 15:44 potential of you introducing an endotoxin, a bacterial endotoxin is quite high at that point. So you just 15:50 really don’t want to take the risk, excuse me. So what practitioners, what 15:56 should we do and what should patients do? Well, for any peptide therapy, we 16:03 want to source our verification. know where the peptide product comes from. Is 16:08 it an FDA approved product? Is it a 503b compounding? A research chemical 16:14 supplier? Is there a certificate of analysis? Request and review this COA. 16:20 And you want it to show purity greater than 95% but ideally greater than 98%. 16:27 You want that identity be identity to be confirmed by mass spectromedy. Uh 16:33 sterility testing should be done. Bacterial endotoxin testing should be done. Batch number matching of the 16:39 product that you received should be done. Proper storage. You want to know that this has been refrigerated or 16:46 frozen as directed once it’s been mixed. Look at the expiration dates for reconstituting your peptides. Track that 16:53 reconstitution date and discarded accordingly like we just talked about. Monitor for your adverse effects. Even 17:01 with the perfect quality control, monitoring for adverse effects is essential with questionable quality and 17:08 vigilance is really critical here. I know it’s frustrating for a lot of patients when they have to get several 17:15 bottles and they only last a week or two. right here, you guys. This is why 17:21 they only last a short period of time because once they’re mixed, they start 17:26 to degrade and they won’t be good and you won’t get the benefit from it. So, 17:31 it’s really important with these research peptides specifically, practitioners should recognize that all 17:38 recommending products without quality assurance violates the fundamental medical principle of first do no harm. 17:45 If a patient is determined to use research peptides despite counseling, providing guidance on quality 17:52 verification, requesting those COAs, using pharmaceutical grade sources when available, proper testing, this all 17:59 reduces harm, but doesn’t constitute necessarily that recommendation. Now, 18:06 that being said, today it’s very difficult to find peptides by the compoundingies because of what the FDA 18:13 has done. So most of the peptides that are available to us have been labeled 18:18 not for human consumption, not because they’re not good products, but because 18:25 of what the FDA did. And this is how these companies have been able to 18:31 continue to provide peptides to the medical community. And if you know you 18:36 have a good company, then you’re, you know, you’re still taking the risk, right? But at the end of the day, the 18:42 reason they’re doing that is to protect themselves from the FDA, from liability. Um, so just kind of know that there is 18:50 some talk in the community with um Bobby Kennedy that this is going to change and 18:55 they are going to bring peptides back to the compounding pharmacies. Now, we don’t know which ones they’re going to 19:01 bring back. Uh, will it be all of them? Will it just be some of them? What’s going to happen here? Um, is it going to 19:07 go to the pharmaceutical companies like our GLP1s did? We don’t know what that’s going to look like quite yet. Um, but it 19:14 is coming and that is positive news. So, let’s talk now about FDA approved 19:21 peptide medications. So, this is the metabolic revolution, right? GLP1 19:28 and our dual increeting agonists. This is an exciting time. GLP-1s are amazing. 19:35 Um, a lot of people are skeptical, a lot of people love them, a lot of people hate them. Whichever side of the fence 19:42 that you’re on, I understand. But I want to talk about the science of it today 19:48 and what it actually means for people. So, the story of GLP1 glucagon like 19:54 peptide one represents one of the most significant advances in metabolic 19:59 medicine in the past several decades. GLP-1 is an accretin hormone. It’s 20:05 gutder derived peptide that potentiates insulin secretion in response to food 20:11 intake. And the body naturally produces GLP-1 in the intestinal L cells, but it 20:17 rapidly degraded by the enzyme DPP4 giving it a halflife of only about 2 20:24 minutes. So this rapid breakdown made in therapeutically impractical until 20:31 research was developed and modified the analoges that resist the enzyme degradation. So for those people who 20:39 never feel full when they’re eating, never feel satisfied when they’re done, this is because their body is either not 20:46 producing enough GLP1 or it’s not getting the signal right. And this is a 20:51 leptin issue. This is an insulin issue. It’s a GLP-1 issue. It’s a complicated 20:56 issue. This is not anything that the person is doing wrong. It’s what is happening to their body. And so GLP1s 21:03 have really revolutionized this. So one particular GLP-1 that we have is 21:09 semiglutide. And this GLP-1 agonist is what changed everything in the world of 21:16 metabolic medicine. Semiglutide is marketed as ompic for type 2 diabetes 21:23 and it’s marketed as WGOI for chronic weight management. It is a modified 21:29 GLP-1 analog with 95 or sorry 94% amino acid sequence uh homology to human 21:37 GLP-1. So it means that it’s it’s just like our own GLP-1 that we make. This 21:42 modification includes specific amino acid substitutions and the addition of C18 21:50 a fatty acid chain which allows the peptide to bind to albumin. Now this 21:56 albumin binding dramatically extends the half-life to approximately one week 22:01 enabling one weekly dosing which is a major advantage over the earlier GLP-1 22:07 agonists that require daily or twice daily injections. The mechanism by which 22:13 semiglutide works is multiaceted. At the pancreatin level, it binds to GLP-1 22:20 receptors on the pancreatic beta cells enhancing glucose depending sorry 22:27 enhancing glucose dependent insulin secretion. This glucose dependency is 22:33 crucial. It means the peptide only stimulates insulin release when blood glucose is elevated. This dramatically 22:41 reduces the hypoglycemic risk compared to insulin or even uh sulfuras. 22:47 Simultaneously semiglutide suppresses glucagon secretion from pancreatic alpha 22:53 cells further improving glycemic control. This is really amazing because 23:00 over the years when we’ve used insulin, which is also a peptide by the way, you 23:05 had to dose it just right because if you didn’t, you would produce so much insulin that it would crash the blood 23:12 sugar and then somebody would have too low of a blood sugar. They’d be hypoglycemic and they’d have to eat more 23:18 sugar and then they’d have to modify the insulin again and the person would be going up and down, up and down, up and 23:24 down all day long. And that created a lot of problems for people and so this 23:30 helps to stabilize that so it is not such an intense change. Now in the GI 23:36 tract semiglutide delays the gastric emptying particularly pronounced during 23:41 the initial weeks of therapy. This slowing of the gastric emptying contributes to the sensation of being 23:48 full and early satiety that patients often describe. However, this effect 23:54 tends to attend to weight over time as the body adapts through the appetite 24:00 suppressing effects generally persist through central mechanisms. So, when we 24:05 talk about what is actually happening, we’re slowing that digestive process down. That’s why people aren’t so 24:11 hungry. It’s why they’re not eating so much. This is why people can develop constipation with these products because 24:17 it’s slowing the body’s digestive tract down. Now some people will call this 24:22 gastroparesis. Um gastroparesis is actually different. 24:28 It is when we lose control over what’s happening in the in the colon like the 24:34 nerves and things like that just stop working. I have never seen that with the GLP1s that we prescribe in micro doing. 24:42 um it’s been documented. It can happen, but again it a lot of it is dosing and a 24:48 lot of it is staying on top of your client and what’s happening and what’s going on and what you’re doing and making sure that they do have good 24:54 motility still. So a lot of these things can be mitigated if you have problems 24:59 with them. Now one of the most profound effects of semiglutide occur in the 25:05 central nervous system. GLP-1 receptors are widely distributed in the brain 25:10 particularly in the hypothalamus and the brain stem area where we are involved in 25:15 appetite regulation. So when when wilding and colleagues published their 25:20 landmark step one trial in the New England Journal of Medicine in 2021, 25:25 they demonstrated that participants receiving 2.4 4 milligrams of semiglutide weekly achieved an average 25:32 weight loss of 14.9% of their body weight over 68 weeks. Now, I want you 25:39 guys to really understand this. We’re talking roughly 15% body weight loss 25:45 over a year, longer than a year. 52 weeks is a year, right? This is 68 25:50 weeks. So, it took longer for them to lose. We’re not talking about giving 25:55 somebody a dose to lose 15% of their body mass in a month or two. That that 26:01 is not healthy for any of us. That is not what we’re talking about doing here. Now, they compared this to placebo and 26:08 the placebo was only 2.4%. So, that is a significant difference. 26:14 And even beyond the numbers, patients reported something very qualitatively different, a reduction in what’s now 26:21 called food noise. Everybody knows what food noise is. We’ve talked about this long before GLP1. It’s that craving. 26:28 It’s that part of your brain that just keeps thinking about I want to eat something. You know, that was actually 26:34 reduced and they didn’t expect to see that happen. Now, this refers to the constant mental preoccupation with food, 26:42 the intrusive thoughts about eating, the difficulty in feeling satisfied. Semi-glutide appears to appears to 26:49 modulate reward pathways in the misolyic system reducing hedonic eating and food 26:57 cravings. Now there are also great cardiovascular effects of semiglutide 27:02 that extend beyond weight loss. Uh the sustained six and select trials 27:07 demonstrated significant reductions in major adverse cardiovascular events uh 27:14 mace in high-risisk populations. The select trial published in 2023 showed 27:20 that semiglutide reduced cardiovascular death, non-fatal myioardial inffection 27:25 and non-fatal stroke by 20% in adults with overweight or obesity and 27:31 established cardiovascular disease but without diabetes. So this suggests that 27:37 mechanisms beyond glucose control and weight loss possibly including 27:42 anti-inflammatory effects, improvements in endothelial function and favorable 27:47 changes to lipid profiles. Now I will tell you the clients that I work with that are on GLP1, 27:53 they will tell you that their inflammation has been significantly reduced. We are also seeing really 28:00 amazing results in lipid profiles. um part of its weight loss, but there is a 28:06 component to this that is lowering the triglyceride levels because it’s related to sugar and how the body’s processing 28:11 it. And we’re seeing better profiles, less need for statins as a result of 28:17 that. If if you want to listen to my episode on statins, I have one on that. Uh they are not my favorite medication. 28:24 I think it’s overprescribed and overused um and not really affecting or 28:29 addressing the problem. So these things can really be helpful. There’s also some 28:34 uh ramblings going on with GLP-1s saying that they may be able to help with 28:40 addiction in the future because of where they’re finding it affecting the brain and how it affects the food noise and 28:47 the cravings that we have for food and the addiction for food. Could it potentially help with other addictions 28:53 down the road? We’ll have to wait and see on that one. So semiglutide’s FDA prescribing information also includes a 29:00 box uh boxed warning about thyroid sea cell tumors. So in rodent studies 29:06 semiglutide caused dose dependent and treatment duration dependent sea cell 29:12 tumors at clinically relevant exposures. So while it’s unknown whether or not 29:17 semiglutide causes uh thyroid cancer tumors in humans and the rodent thyroid biology 29:26 differs significantly from humans, the drug is contraindicated in patients with a personal or family history of 29:33 medillary thyroid carcinoma or in patients with multiple endocrine neopl neoplasia syndrome type two. it is 29:42 uh contraindicated for safety effects with that. Um I have seen endocrinologists okay GLP1s to be used 29:50 in patients who’ve had other forms of thyroid cancer just not the meillary 29:55 thyroid cancer. So there is possibility there. Now the most common side effects 30:00 are gastrointestinal. It’s nausea affects about 20 to 44% of patients 30:06 depending on the formulation with diarrhea, vomiting, constipation, abdominal pain, and also frequently 30:13 reported in clinical trials. I see this in my clinic, too, especially dose dependent. Um, and it happens early on 30:20 when you’re first starting the medication, but seems to settle out over time. The one that I would add to this 30:26 that I don’t think they have on here is an increase in acid reflux. We also see that quite often uh especially in people 30:33 who suffer with acid reflux to begin with. Now these effects are typically most 30:40 pronounced during the escalation and they like I said often improve over time 30:45 but more serious but less common adverse effects include acute pancreatitis. 30:51 The medication needs to be discontinued immediately if this is confirmed. You can see some diabetic retinopathy 30:57 complications in patients with pre-existing retinopathy and acute kidney injury. Um, this usually happens 31:05 secondarily to dehydration from the GI effects. There are some gallbladder disease um that can occur and people who 31:13 have a sensitive gallbladder will describe uh discomfort with that. I’ve 31:18 even seen some people who’ve had their gallbladder out on GLP1s at the higher doses complain of similar pain that they 31:25 used to have when their gallbladder was in. So, really important to just kind of monitor these symptoms and work closely 31:32 with somebody that understands them and can be on top of them quite quickly if this happens. Excuse me. From an 31:39 integrative medicine perspective, semiglutide really represents a powerful tool, but it’s not a standalone 31:46 solution. Remember, the medication addresses one aspect of the metabolic dysfunction, the signaling systems 31:53 controlling appetite and glucose homeostasis, but it doesn’t address the root cause that led to the metabolic 32:00 disease in the first place. Patients who rely solely on the medication without addressing the ultrarocessed food 32:07 consumption, the ccadian disruptions, the chronic stress, the sleep apnea, or 32:12 underlying hormonal imbalances often experience weight regain when the medication is discontinued. 32:20 The drug is also not a substitute for addressing the emotional and psychological drivers of eating 32:26 behavior, including the unresolved trauma that may manifest as emotional eating. I think this is really important 32:33 because we don’t address the trauma issue enough with clients and we need to 32:38 be looking at that. There is a huge trauma effect out there these days that is I don’t want to say leading to or 32:45 causing but it is definitely contributing to chronic illness and it’s not being talked about enough. So we 32:52 really need to be talking about this and addressing this trauma aspect. Now the next GLP that one that I want to talk 32:59 about is trespathide. This is a dual agonist. It takes center stage. It is my 33:05 favorite GLP one. Trisepatide is marketed as Mangjaro for type 2 diabetes 33:11 and Zepbound for chronic weight management and it represents the next 33:16 evolution in increantbased therapy. This is a dual agonist a 39 amino acid 33:23 synthetic peptide structurally based on the human glucose dependent insulin tropic peptide so GIP sequence but 33:31 modified to activate both the GIP receptors and the GLP1 receptors. So the 33:37 addition of the GI GIP agonism to the GLP1 agonism appears to create this 33:46 synergistic effect that goes beyond simply adding the two mechanisms together. So the GIP like GLP-1 is an 33:55 increant hormone secreted by what is called the K cells in response to nutrient intake. It enhances glucose 34:02 dependent insulin secretion but it also effects on atapost tissue metabolism 34:09 potentially improving the insulin sensitivity in fat cells and influencing 34:14 how the body stores and metabolizes fat. So some research suggests that GIP may 34:20 also have effects on energy expenditure though this remains an area of 34:26 investigation. So basically what we’re saying is this drug may actually help 34:32 people who are insulin resistant or insulin sensitive, not just somebody who 34:38 has problems with glucose control. So, this is super exciting because it opens 34:43 up the door for all of these people for decades that we’ve been trying to manage with insulin resistance and trying to 34:50 prevent diabetes and honestly most of the time have been unsuccessful 34:56 unless you can keep your diet at 50 grams of carbs or less a day, which is extremely difficult. Um, and take some 35:04 supplements that may or may not work and or take some metformin that may or may not help. this drug actually really 35:11opens that up and helps in that capacity. So there was a clinical trial 35:17 called the surmount clinical trial which demonstrated that trespathide produces 35:22 even more substantial weight loss than semiglutide. In the surerount one trial published by uh J tree I might have said 35:31 that wrong. I apologize if I slaughtered your name and colleagues in the New York England Journal of Medicine in 2022. 35:38 Participants receiving the highest dose of trespide, which is 15 milligrams, achieved an average weight loss of 20.9% 35:47 of their body weight over 72 weeks, compared to 3.1% with placebo. This 35:54 level of weight loss approaches what’s typically only seen in beriatric surgery. So, this is amazing because if 36:02 this medication works and we don’t have to do beriatric surgery, stomach stapling basically, um, oh my gosh, it’s 36:11 amazing. There are so many complications and risks that go with stomach stapling and the different procedures that they 36:17 do these days. People don’t absorb their nutrients properly. They have to do liquid nutrients. It’s very complicated. 36:24 It’s very challenging. Many of these people gain their weight back. Um, and 36:30 this procedure is not fun to go through. So, if we could change that and change 36:35 the lives of people who’ve really been struggling, it is amazing. And I will tell you that I have seen this work. I 36:42 have seen people lose 100 150 pounds on these medications over a year or two 36:50 period of time. It is definitely slower than beriatric surgery on some standpoints, but that is okay. You don’t 36:56 want that rapid weight loss. It’s not good for you. It’s not healthy for you. It doesn’t look well. You know, we want 37:03 to do this safely and effectively in the best way that we can possibly do that for you. Now, the adverse effect profile 37:10 is similar to semiglutide. It’s dominated by gastrointestinal effects. 37:15 Nausea, diarrhea, decreased appetite, vomiting, constipation. These were all commonly reported in the surmount 37:22 trials. And like semiglutide, tricepide carries a blackbox warning regarding the 37:27 thyroid sea cell tumors based on the rodent data and it shares the same contra indications in patients with a 37:34 family history of thyroid cancer and men too. So the mechanism behind why 37:40 tepatide often produces more substantial weight loss than GLP-1. The agonism 37:45 alone remains under investigation, but it may relate to the complimentary effects on the different aspects of 37:51 energy homeostasis or to GIP’s effects on atapost tissue and potentially on 37:58 central central nervous system pathways that GLP1 alone doesn’t fully address. 38:03 Now patients often report even more profound reductions in food noise with tricepide compared to GLP1 and uh sorry 38:12 GLP1 the agonists through this is anecdotal and hasn’t been regularly 38:17 quantified in quality studies. So I’ve done both uh personally and in my 38:22 practice. I really like trespide better than semiglutide. For me I had too many side effects with semiglutide. uh I had 38:30 less side effects with trespathide. I also plateaued on semiglutide which I 38:35 didn’t really care for. And with Tresepide, I haven’t plateaued and I’ve been able 38:42 to lose about 25 pounds in um a year and a half and I’ve been able to maintain 38:49 that. Um and I continued to use it because I do have a strong family history of cardiovascular disease. And 38:56 if this could help me so that I don’t follow my family lineage with cardiovascular disease, I am all for 39:03 trying to do that. I’ve watched too many of my family members suffer from this. I’ve lost my dad at a very young age. I 39:09 lost my grandfather at a young age to it. All of their brothers to this. And I don’t want to be that same person. So 39:16 that is why I chose to do that. And I think it’s really important for us to take a look at that and understand that. 39:24 Now, I know this has been a really long podcast and I don’t typically do podcasts this long. I have a whole host 39:31 of information on additional peptides. So, I’m going to break this up for you 39:36 guys and I’m going to do another episode and we’re going to pick up where we left off here with these peptides so that we 39:43 can actually start to dive into different peptides as well. So, check 39:48 out my next podcast show when we’re going to dive into the peptides that 39:54 talk about sexual wellness, immune function, and all the other cool things 39:59 that we can do with peptides. So until then, remember to like, share, and 40:04 subscribe. It really helps us get out to other people and share our information, 40:10 and join us for our next episode as we continue the talk about peptides. 40:15 Welcome to Let’s Talk Wellness Now, where we bring expert insights directly to you. Please note that the views and 40:21 information shared by our guests are their own and do not necessarily reflect those of Let’s Talk Wellness Now, its 40:28 management, or our partners. Each affiliate, sponsor, and partner is an 40:34 independent entity with its own perspectives. Today’s content is provided forformational and educational 40:40 purposes only and should not be considered specific advice, whether financial, medical, or legal. While we 40:48 strive to present accurate and useful information, we cannot guarantee its completeness or relevance to your unique 40:56 circumstances. We encourage you to consult with a qualified professional to address your 41:01 individual needs. Your use of information from this broadcast is entirely at your own risk. By continuing 41:08 to listen, you agree to indemnify and hold Let’s Talk Wellness Now and its 41:14 associates harmless from any claims or damages arising from the use of this 41:20 content. We may update this disclaimer at any time and changes will take effect 41:26 immediately upon posting or broadcast. Thank you for tuning in. We hope you 41:31 find this episode both insightful and thought-provoking. Listener discretion 41:36 is advised.The post Episode 256 – How Peptides Work, Benefits, and FDA-Approved vs Off-Label Use Explained first appeared on Let's Talk Wellness Now.

President Donald Trump's brief mention of Iran in his State of the Union address was still short of a complete argument for how and why striking Iran, which would risk a wider Middle East conflict, would further U.S. interests. Also: today's stories, including how U.S. President Donald Trump's new retirement plan builds on a bipartisan model; what Trump's view of U.S. military power could mean for Iran-US talks; and how some prominent U.S. universities are paring back campus spending in response to endowment tax hikes. Join the Monitor's Christa Case Bryant for today's news.

How Closely Should You Monitor Your Law Firm Team U.S. law firm owner doing $300k–$2M/year? Get a free Law Firm Profit & Tax Checkup where I review your books and tax setup and highlight a few ways similar firms are keeping more of what they earn. Book your checkup here: https://bigbirdaccounting.com

This episode was originally released on 6/1/2021. While new episodes of Breaking Walls are on hiatus I'll be going back and posting the older episodes. ____________ In Breaking Walls episode 116, it's June of 1955 and network radio is in uncharted territory. TV's encroachment has the entire industry looking for new ideas. We'll focus on the launch of one of the most successful—Monitor—which will air in some form or fashion until January of 1975. —————————— Highlights: • The Changing Network Radio Landscape • Who Is Sylvester “Pat” Weaver? • Monitor Origins • Building the Team • Radio Central • The Soft Launch • An Auto Tragedy at Le Mans • Going to San Quentin Prison • Lots of Tunes in Remote • A Potential United Automobile Workers Strike • Dave Garroway Interviews Marilyn Monroe, live on Monitor • Fibber McGee and Gildy Too • Here's Henry Morgan • Monitor's Last Hour • Miss Monitor Finally Makes an Appearance • The Full Launch • Looking Ahead in Time and Space —————————— The WallBreakers: thewallbreakers.com Subscribe to Breaking Walls everywhere you get your podcasts. To support the show: patreon.com/TheWallBreakers —————————— The reading material used in today's episode was: On the Air - By John Dunning Monitor: Take 2: By Dennis Hart Network Radio Ratings — by Jim Ramsburg Articles from: Broadcasting-Telecasting Magazine Monthly Labor Review The New York Daily News The New York Times Newsweek Printer's Ink Variety As well as the websites: accordions.com/ for their interview with Art Van Damme Dennis Hart's monitorbeacon.net/ tipsontables.com/ —————————— On the interview front: • Pat Weaver was interviewed for Fred Allen's May 29th, 1956 Biography In Sound. • Ben Grauer was interviewed for NBC's 50th Anniversary and Westinghouse' 50th Anniversary. • Dave Garroway and Willard Waterman spoke with Chuck Schaden. Hear their full chats at SpeakingOfRadio.com. • Jim Jordan was with Dick Bertel and Ed Corcoran for WTIC's The Golden Age of Radio. Hear this full interview at Goldenage-WTIC.org.

Brendan! didn't make it down to Florida after all, leaving Andy and PJ to roam around the SoFi Dome by themselves for Monday's Ballfrogs match. Andy shares plenty of takeaways from his in-person experience, leading to a wider conversation regarding the future of TGL. What's next for the screen golf league after the ESPN TV deal expires? How can the in-person experience level up? Is there a risk of players leaving after the second season wraps up? The two then move on to the Schedule for the Week and first discuss the Cognizant Classic in The Palm Beaches. The Florida Swing begins this week and Andy has his list of 5 Guys to Monitor, including a player returning on a major medical and Brooks Koepka once again playing his hometown event. Everybody makes a One-and-Done pick despite a weak field after many top players withdrew from the event following the Genesis Invitational. Andy tosses out a Game Within the Game for the South African Open, which he also names as his event of the week! It's a quick wrap -up at the end, as the only big news is a very special birthday for a podcast favorite!

The United States has amassed the largest force since the war in Iraq. Iran threatens an all-out response to any attack, even if limited. As they prepare for nuclear diplomacy in Geneva to avoid conflict, each side appears to be misreading the other. Also: today's stories, including how as the world fights over Greenland, its people double down on their own values; a look at space-based data centers; and how mobile libraries are upending the belief among many Pakistanis that reading is a pastime reserved for the elite. Join the Monitor's Ira Porter for today's news.

President Donald Trump tried to respond boldly with new tariffs to counter a Supreme Court ruling that went against him. But the White House's economic calculus is in flux as global leaders reconsider trade deals. Also: today's stories, including how violence that often follows the takedown of a drug cartel leader is a public reminder that peace might not be imminent; how some economists see income taxes as a drag on productivity; and how one Monitor reporter fell in love with the roses in the Ukrainian city of Pokrovsk. Join the Monitor's Kurt Shillinger for today's news.

President Donald Trump tried to respond boldly with new tariffs to counter a Supreme Court ruling that went against him. But the White House's economic calculus is in flux as global leaders reconsider trade deals. Also: today's stories, including how violence that often follows the takedown of a drug cartel leader is a public reminder that peace might not be imminent; how some economists see income taxes as a drag on productivity; and how one Monitor reporter fell in love with the roses in the Ukrainian city of Pokrovsk. Join the Monitor's Kurt Shillinger for today's news.

"The Boys" are back in town for this Wednesday episode, joining Brendan to preview the PGA Tour's return to Riviera. Joseph starts out with a take regarding this week's event "honoring" the local community in the Palisades, setting the tone for this episode early. Brendan, Joseph, and PJ unpack Tiger Woods's pre-tournament press conference, in which he discussed his chances of returning to competitive golf in 2026, a potential Ryder Cup captaincy, and the PGA Tour schedule changes. It seems like Tiger may tee it up on the Champions Tour after all, with PJ already wanting to make travel arrangements for a few select stops later this year. Woods also gave some insight into the hard work he's been putting in on the 2027 PGA Tour schedule, alluding to the California swing being later in the summer, maybe as part of the playoffs. Joseph loves the idea of Tiger's mark on the game being a playoff schedule that he created, and Brendan thinks that the Genesis Invitational should be a "jumbo event" moving forward. PJ runs through his five favorite tee times for the first two rounds and also sets the scene for this week's Aon Swing 5 vs. Sponsor Exemption tracker, now a five-on-five fight for this week only! Joseph passes along Andy's 5 Guys to Monitor before highlighting a favorite tee time of his own. He also initially declines to make a One-and-Done pick before Brendan bullies him into it on air. Brendan has some sourced reporting from the Magical Kenya Open, sharing details about the caddie fees and "driving range" at this week's DP World Tour event. In news, Justin Thomas will return to pro golf next week in the SoFi Dome... no word yet on if he's playing outdoor golf as well. To round out the show, Joseph and Brendan preview the first-ever Fried Egg Golf Anonymous Survey, tiering the best players in the men's game.